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ABSTRACT 
The main focus of the current PhD thesis is to develop novel strategies for the preparation 
of 13N-labelled radiotracers, which might potentially be used in the future as probes with 
application in the field of in vivo imaging.  
During the last decades, a plethora of radiotracers labelled with different positron 
emitters for the in vivo visualization of biological, physiological or pathological processes 
using Positron Emission Tomography (PET) have been developed and reported in the 
literature. Most of these tracers are labelled with Fluorine-18 (18F), Carbon-11 (11C), 
Gallium-68 (68Ga), Copper-64 (64Cu) or Zirconium-89 (89Zr). However, the use of Nitrogen-
13 has been restricted mainly due to its short half-life (9.97 min). Despite this drawback, 
Nitrogen is present in the majority of biologically active molecules. Hence, the 
incorporation of the positron emitter 13N to the toolbox of PET chemists would represent a 
unique opportunity to label a wide variety of molecules in different positions, or to 
prepare radiolabelled molecules for which incorporation of the above mentioned longer-
lived positron emitters is challenging or impossible.  
The work performed in this PhD thesis has been divided in three main parts. First, a 
method for the preparation of 13N-labelled aromatic azides was developed. After 
identification of potential synthetic routes, the most convenient one (based on the reaction 
of aromatic diazonium salts with hydrazoic acid) was selected. Different experimental 
approaches were tackled in order to gain knowledge regarding the precise mechanism of 
the reaction, which ultimately enabled the selection of the optimal experimental design. 
Experimental results combined with computational studies provided unambiguous 
information to elucidate the reaction mechanism, which occurs via acyclic zwitterionic 
intermediates.  
The second part of the PhD thesis focused on the development of synthetic strategies for 
the preparation of 13N-labelled triazoles via (3+2) Huisgen cycloaddition, by reaction of 
labelled azides (labelled precursor) with alkynes and aldehydes. The experimental 
conditions were optimized and the methodology was applied to the preparation of 
different 13N-labelled triazoles. A short library of compounds could be synthesized, 
including one specific molecule with potential application as β-amyloid marker. The 
procedure for the preparation of this compound was fully automated using one of the 
synthetic boxes currently available at CIC biomaGUNE.  
The last part of this PhD thesis pursued the preparation of 13N-labelled tetrazoles by 
reaction of the labelled azides with nitriles. However, this reaction is very slow under non-
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radioactive conditions, and requires the use of a catalyst. Because the catalysts reported in 
the literature were anticipated not to be convenient in radioactive conditions, novel 
nanostructured, copper-based heterogeneous catalysts were developed and tested in a 
small library of tetrazoles in cold conditions. After optimization of the experimental 
conditions and selection of the most promising catalyst, one selected tetrazole was 
labelled with Nitrogen-13.  
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RESUMEN 
La Tomografía por Emisión de Positrones (PET) es una técnica de imagen molecular que 
permite conocer, de manera mínimamente invasiva y prácticamente a tiempo real, la 
distribución espacio-temporal de un radiotrazador marcado con un isótopo emisor de 
positrones tras su administración a un organismo vivo. Entre las aplicaciones de la PET en 
el entorno clínico destacan el diagnóstico precoz, la evaluación de la respuesta al 
tratamiento y el desarrollo de nuevos fármacos. En el entorno pre-clínico, supone una 
herramienta fundamental para afrontar cuestiones biológicas y fisiológicas inabordables 
mediante otras técnicas y puede contribuir a la elucidación mecanística de ciertos 
procesos biológicos o patológicos.  
La aplicación de la PET va asociada al uso de un radiotrazador marcado con un isótopo 
emisor de positrones. Dichos isótopos (por ejemplo, 18F, 11C, 13N, 15O) pueden generarse 
utilizando ciclotrones biomédicos comerciales y presentan períodos de 
semidesintegración cortos. Tradicionalmente, la mayoría de los grupos de investigación 
han centrado sus esfuerzos en el desarrollo de radiotrazadores marcados con Flúor-18, 
cuya vida media de 109.8 minutos permite su distribución desde unidades de producción 
centralizadas a centros satélite, y con Carbono-11, ya que su vida media no es 
extremadamente corta (20.4 minutos) y las formas químicas en las que puede obtenerse 
([11C]CO2, [11C]CH4) presentan una elevada versatilidad sintética. El uso de otros 
radionucleidos de vida media más corta (por ejemplo Nitrógeno-13, T1/2=9.97 minutos) se 
ha visto históricamente muy restringido y no hay prácticamente trabajos publicados 
relacionados con el desarrollo de estrategias sintéticas con estos isótopos. 
La reciente salida al mercado de pequeños ciclotrones más económicos, de menor tamaño 
y que permiten producir cantidades moderadas de isótopos emisores de positrones, unida 
a la recientemente emergente tecnología de microfluidos y su aplicación al área de la 
radioquímica (su eficacia ha sido probada en procesos químicos en los que intervienen 
isótopos PET como 18F y 11C), podrían cambiar en los próximos años el panorama de la 
imagen PET desde la situación actual hacia un escenario en el que los radiotrazadores se 
producirían in situ, en pequeños lotes y bajo el criterio “dosis bajo demanda” (una 
producción para un estudio). En este contexto, cobrarían importancia los radionucleidos 
de vida media más corta, por ejemplo el Nitrógeno-13, resultando fundamental el 
desarrollo de nuevas estrategias sintéticas que permitan preparar radiotrazadores 
marcados con estos isótopos de manera eficiente, rápida y reproducible. Hasta la fecha, 
tan sólo se han descrito unas pocas estrategias sintéticas para la incorporación de este 
radioisótopo a moléculas bioactivas.  
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Durante la última década, el grupo de Radioquímica e Imagen Nuclear de CIC biomaGUNE, 
liderado por el Dr. Llop y en el cual se ha llevado a cabo la presente tesis doctoral, ha 
desarrollado nuevas estrategias sintéticas para la radiosíntesis de aminoácidos marcados 
con 13N, a través de reacciones enzimáticas y utilizando [13N]NH3 como agente de marcaje. 
Se ha propuesto un nuevo método para la reducción química y biocatalizada de [13N]NO3- a 
[13N]NO2-, donde además se ha demostrado que el uso de [13N]NO2- como agente de 
marcaje es útil para la radiosíntesis de [13N]nitrosaminas, [13N]nitrosotioles y derivados 
[13N]azo.  
En esta tesis doctoral, el trabajo experimental se ha centrado en el desarrollo de nuevas 
estrategias para la preparación de compuestos marcados con 13N utilizando [13N]NO2- 
como agente de marcaje, y el trabajo se ha dividido en tres partes, que corresponden a los 
capítulos 3, 4 y 5 del presente documento. 
La primera parte del trabajo (capítulo 3) consistía en desarrollar estrategias sintéticas 
para la preparación de arilazidas marcadas con 13N, que posteriormente pudieran ser 
utilizadas como sintones para la preparación de moléculas más complejas. Con este 
objetivo, se propuso una metodología sintética para la preparación de azidas marcadas 
con 13N. En primera instancia, se consideró la posibilidad de utilizar la reacción de Dutt-
Wormall. Este método funciona muy bien en condiciones no radiactivas e implica la 
hidrólisis básica de un diazoaminosulfinato aromático, pudiéndose sintetizar fácilmente a 
partir de sal de diazonio aromático y alquil- o aril-sulfonamida. De este modo, se abordó la 
síntesis de fenilazida marcada con 13N mediante la reacción de Dutt-Wormall en 2 pasos 
(Figura 1): (i) Adición de [13N]NO2- a una solución de anilina (0.25 mmol) en HCl frío (0.1 
ml de HCl al 37% en 0.15 ml de agua), t=4 min, T = 0°C; y (ii) tras extracción con 
diclorometano para eliminar el exceso de anilina, la fase acuosa de la mezcla de reacción 
se añadió gota a gota a un vial precargado con una solución fría de p-toluensulfonamida 
(0.25 mmol) en NaOH (1.60 Mmol en 1 ml de agua, t = 1 min, T = 0°C. 
El método presentado en la Figura 1 presentaba ciertas limitaciones, por ejemplo la 
necesidad de dos etapas de purificación mediante extracción líquido-líquido, que son 
complejas de implementar en el entorno radiactivo. En consecuencia se exploraron 
alternativas más convenientes. De este modo, se encontró un método para la formación de 
fenilazidas basado en la reacción de sales de diazonio con ácido hidrazóico generado in 
situ (por reacción de monohidrato de hidrazina con nitrito de sodio en medio ácido). Este 
método fue abordado siguiendo dos rutas diferentes, esquematizadas como A y B en la 
Figura 2. 
Resumen 
ix 
 
 
 
Figura 1. Esquema de la reacción utilizada para la preparación de fenilazida marcada con 13N 
mediante reacción de Dutt-Wormall. 
 
 
Figura 2. Estrategias sintéticas (A y B) utilizadas para sintetizar fenil-azida marcada con13N([13N]2 
en la Figura). 
Como puede observarse en la Figura 2, en esta reacción se libera gas nitrógeno [13N]N2 
como subproducto, lo cual puede tener un impacto negativo en el rendimiento 
radioquímico global de la reacción. Para lograr las condiciones óptimas, se decidió en 
primera instancia explorar ambas rutas sintéticas. Ambas estrategias sintéticas 
condujeron a la formación de fenil-azida marcada con 13N. Sin embargo, la cantidad de 
azida marcada obtenida en la ruta B era significativamente más alta que la obtenida en la 
ruta A. Cuando se seguía la ruta A, la mitad de la radiactividad se perdía como [13N]N2, 
mientras que en la ruta B la radioactividad se transfería de manera prácticamente 
cuantitativa a la azida.  
En vista de los resultados, se decidió abordar estudios computacionales en colaboración 
con el profesor Fernando P. Cossío (UPV-EHU) con el fin de determinar el mecanismo de la 
reacción. Los estudios computacionales confirmaron que la formación de la azida 
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transcurre a través de un mecanismo de reacción stepwise pasando por intermedios de 
reacción zwitteriónicos y acíclicos. De dicho trabajo resultó la primera publicación de esta 
tesis doctoral [1].  
La segunda parte del trabajo, que constituye el capítulo 4 de la presente tesis doctoral, 
consistió en el desarrollo de estrategias para la preparación de triazoles marcados con 13N 
mediante cicloadición (3+2) de Huisgen entre azidas aromáticas (marcadas con 
Nitrógeno-13) y alquinos. Con el fin de preparar la cicloadición  (3+2)  de Huisgen bajo 
condiciones radioactivas, la reacción se llevó a cabo utilizando fenilazida marcada con 13N 
(utilizando la metodología desarrollada en el capítulo 3) y fenilacetileno usando diferentes 
catalizadores de cobre. Finalmente, se demostró que el [(Icy)2Cu]PF6 resultaba ser el 
mejor catalizador para la preparación de triazol marcado con 13N. Tras estos alentadores 
resultados, se decidió extender la metodología para la preparación de otros triazoles 
funcionalizados utilizando otros alquinos, para  lo cual se preparó una pequeña librería de 
triazoles marcados con 13N (Figura 3). 
 
Figura 3. Esquema del proceso de síntesis en 4 etapas seguido para la preparación de triazoles 
marcados con 13N mediante la  reacción de azidas marcadas con 13N con alquinos (a) y aldehídos 
(b). 
En vista de estos resultados, se decidió ampliar el trabajo explorando la posibilidad de 
preparar triazoles marcados con 13N mediante reacción de la azida marcada con un 
aldehído.  
[13N]4.1
[13N]4.2
[13N]4.3
[13N]4.4
[13N]4.5
[13N]4.6
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Una vez optimizadas las condiciones experimentales, se procedió a la automatización del 
proceso de síntesis para uno de los compuestos [13N]6 en la Figura 3), que podría tener 
aplicación como marcador β-amiloide. Para ello, se utilizó un módulo automático para el 
cual se tuvo que adecuar la configuración, tal y como se muestra en la Figura 4. De la 
ejecución de este trabajo resultó la segunda publicación de esta tesis doctoral [2]. 
Figura 4. Representación esquemática del módulo de síntesis automatizado utilizado para la 
producción de [13N]. Los viales 1-8 se indican con números verdes. Las posiciones normalmente 
abiertas para las válvulas de tres vías se indican con un punto. Todas las válvulas de dos vías están 
cerradas. 
La última parte del presente trabajo, incluido en el capítulo 5 de esta tesis doctoral, ha 
consistido en el desarrollo de nuevas estrategias para la preparación rápida y eficiente de 
tetrazoles marcados con 13N. A pesar de que los tetrazoles han sido marcados con 
Nitrógeno-15, la síntesis de tetrazoles marcados con 13N no tiene precedente. Según la 
literatura, las reacciones ya descritas por calentamiento convencional requieren tiempos 
de reacción muy largos, que no son compatibles con la vida media corta del Nitrógeno-13. 
Por esta razón, se exploró la viabilidad de alternativas como el calentamiento por 
microondas. Tras observar que existía muy poca información referente a la síntesis de 
tetrazoles utilizando catalizadores heterogéneos mediante microondas, se decidió abordar 
el desarrollo de nuevos catalizadores heterogéneos basados en nanotecnología que 
permitieran la conversión de azidas en tetrazoles de una manera rápida y eficiente. 
1 2 3 4 5 6 7
8
9
FINAL VIAL
FILTER
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Para lograr este objetivo, se prepararon catalizadores heterogéneos inorgánicos, nano 
estructurados y basados en cobre, y se ensayaron en condiciones frías (no radiactivas). 
Concretamente, se desarrollaron y ensayaron tres catalizadores, denominados en el 
presente trabajo como 50%Cu-Al, 30%Cu-Cr-Al y 20%Cu/SiO2. En primer lugar, se 
procedió a una caracterización rigurosa de los catalizadores mediante difracción de rayos-
X (XRD), microscopía electrónica de transmisión (TEM) y espectroscopia de desorción 
térmica (NH3-TPD). Una vez caracterizados, los catalizadores desarrollados (y otros 
comúnmente utilizados en la preparación de tetrazoles) se ensayaron en la síntesis de 
tetrazoles mediante cicloadición [3+2] a partir de los correspondientes nitrilos y azidas 
sódicas, utilizando para ello calefacción por microondas (Figura 5).  
 
Figura 5. Síntesis de 1H-tetrazoles 5-sustituidos por reacción de azida de sodio con nitrilos. 
 
Tras optimización de las condiciones experimentales se seleccionó el que presentaba 
mayor actividad catalítica (30%Cu-Cr-Al) y éste se utilizó para abordar la síntesis de un 
tetrazol (compuesto 5.1 en la Figura 5) en condiciones de radiactividad. Debido a ciertas 
limitaciones técnicas, en este caso la calefacción se llevó a cabo mediante métodos 
convencionales; aun así, pudo identificarse la formación del compuesto deseado marcado 
con nitrógeno-13.  Para este trabajo, se ha preparado el manuscrito que ha sido enviado a 
una revista científica (New Journal of Chemistry) para su evaluación y posible publicación.  
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1.  INTRODUCTION  
1.1. MOLECULAR IMAGING 
Molecular imaging can be defined as a set of non invasive techniques that allow the 
visualization of cell function and the monitoring of molecular processes in living 
organisms. Contrary to traditional imaging techniques, molecular imaging uses 
biomarkers, which can interact with the surrounding. The images obtained are a result of 
the molecular changes taking place.  
Molecular imaging has opened a wide range of possibilities for the investigation of 
biological, physiological and medical processes which cannot be studied using other 
techniques. Nuclear imaging techniques such as positron emission tomography (PET) or 
single photon emission computerized tomography (SPECT), together with 
optical/fluoresce imaging and magnetic resonance spectroscopy (MRS) are the most 
widely utilized molecular imaging techniques.   
Molecular imaging techniques usually provide very poor anatomical information (see 
Figure 1.1).  
 
Figure 1.1: Representative illustration of the information provided by different in vivo imaging 
modalities. Obtained from [1]; CT: Computed tomography; MRI: Magnetic resonance imaging, OI: 
optical imaging; US: Ultra sound imaging. 
For example, PET and SPECT images just provide information about the spatiotemporal 
distribution of a labelled entity after administration to a living organism (see section 1.2 
for details about PET). However, no information about the anatomical localization of the 
CHAPTER 1: Introduction 
2 
 
radioactive signal can be obtained (see Figure 1). Because of this, molecular imaging 
techniques are usually combined with anatomical techniques, able to provide accurate 
anatomical information. The combination of the resulting images (multimodality) offers 
information at anatomical and molecular levels. Anatomical modalities include magnetic 
resonance imaging (MRI), ultra-sound imaging (US), X-ray imaging and computed 
tomography (CT). 
None of the imaging modalities are perfect: They can just provide certain information and 
have a collection of intrinsic limitations. Thus, while nuclear imaging (PET and SPECT) 
offer unparalleled sensitivity, they offer a poor resolution, which is usually in the range of 
1 mm in the preclinical setting and a few mm in clinical systems. On the contrary, MRI can 
offer high resolution (up to a few micrometers) while its sensitivity is very low. As a 
consequence, the application of one modality or another will depend on the problem 
under investigation and often the combination of two or more modalities will provide the 
most accurate data.  
The description of the different imaging modalities including their principles and 
applications is out of the scope of this chapter. Only an introduction to the imaging 
modality of application in the context of the current PhD thesis (PET) will be provided.    
1.2. POSITRON EMISSION TOMOGRAPHY 
1.2.1. Overview 
Positron emission tomography (PET) is an in vivo and non-invasive molecular imaging 
technique based on the administration of compounds labelled with short-lived positron-
emitting radionuclides to obtain three-dimensional images of functional processes in 
animals and/or humans. Typical isotopes used as radionuclides in PET are fluorine-18 
(18F), carbon-11 (11C), nitrogen-13 (13N) and oxygen-15 (15O) (see Table 1.1). These 
radionuclides are incorporated into biological compounds that play a specific role in living 
organisms. 
Table 1.1. Most commonly used positron emitters and their physical properties.  
Radionuclide Half-life (min) Max. Energy (MeV) Max. Range (mm)* 
Fluorine-18 109.8 0.69 2.4  
Carbon-11 20.4 0.96 4.1  
Nitrogen-13 9.98 1.19 5.4  
Oxygen-15 2.05 1.70 8.0  
* In water 
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Positron emitters undergo radioactive decay by emitting a positron, which is the 
antiparticle of the electron, with equivalent mass but positive electrical charge. After 
radioactive decay, the emitted positron interacts with other charged particles while losing 
its kinetic energy. When most of this energy has been lost and the positron is almost at 
rest, it interacts with an electron of a surrounding atom in a process called annihilation, 
which results in the emission of a pair of gamma rays with energies of 511 keV each and 
travelling 180° from each other (see Figure 1.2a). The distance between the locations 
where the radioactive decay and the annihilation take place is called positron range, and 
depends on the energy of the emitted positron and the media. Positrons are emitted 
simultaneously with one neutrino, and hence positrons are not emitted at one single 
energy, but with an energy distribution. For example, Nitrogen-13 has a maximum energy 
for positron emission of 1.19 MeV, which results in a maximum range in water of 5.4 mm 
(Table 1.1). Typical positron emitters have maximum positron ranges of a few mm in 
water. The positron range has an effect on the resolution of the images acquired using 
PET: The larger the range of the positron, the lower the spatial resolution achieved.  
The generation of the above-mentioned gamma rays (resulting from the annihilation 
process) is the basis of PET: High-energy gamma rays can travel though biological tissues 
without suffering significant scatter or attenuation, and can be detected and quantified 
using specific instrumentation and tomographic reconstruction algorithms. Hence, when a 
tracer containing a positron emitter is administered to an organism, the high-energy 
gamma rays produced can escape from the body and be detected by an external ring of 
detectors as a coincident event (Figure 1.2b).  
 
Figure 1.2. (a) Schematic representation of the annihilation process of one positron and one 
electron, with subsequent emission of two gamma rays. (b) Representation of a PET camera. The 
two photons emitted after the annihilation process are detected simultaneously by two detectors of 
the ring, placed around the subject under investigation. 
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The direction of the incident rays is determined as the line crossing the two detectors, and 
hence PET imaging relies in back-to-back detection heads (coincidence detection). The 
detection of hundreds of thousands of such coincident events permits the reconstruction 
of a 3D-image that contains information about the distribution of the radiolabelled tracer 
within the organism.  
 
 
Figure 1.3. Intracellular metabolism of glucose and [18F]FDG. Both are taken up by cells by means 
of glucose transporters (GluT). Once into the cell, they are phosphorylated to glucose-6-phosphate 
and [18F]glucose-6-phosphate, respectively. Unlike glucose, [18F]glucose-6-phosphate does not 
undergo further metabolism and is trapped in the cell. 
The mainstay of PET imaging has been 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG or FDG), 
a radio-fluorinated glucose metabolism marker widely adopted in clinical oncology, which 
has made an unparalleled contribution in the early diagnosis and evaluation of the 
response to treatment of a wide variety of tumours. The principle behind the application 
of FDG is quite intuitive (Figure 1.3): In this radiotracer, an 18F atom is incorporated in the 
2 position of glucose in substitution of a hydroxyl group. After administration to a living 
organism, [18F]FDG is distributed all over the organism and then taken up by cells through 
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the same pathways as glucose (glucose transporters), phosphorylated and trapped in the 
cells, because subsequent metabolic steps cannot occur due to the presence of the fluorine 
atom (this is known as metabolic trapping); as a result, the [18F]FDG concentration 
increases in proportion to the rate of utilization of glucose, and therefore it can be used as 
an indirect proliferation marker. It is well known that most tumours present accelerated 
(and anaerobic) metabolism and hence the amount of FDG uptake can aid in the 
identification and classification of different tumours.    
The widespread installation of biomedical cyclotrons and the rapid advances in imaging 
technologies have opened new avenues in the potential applications of PET far beyond 
medical diagnosis. PET can effectively provide early and reliable answers to key questions 
emerging during the drug development process, e.g. the elucidation of pharmacokinetic 
properties of new chemical and biological entities, the determination of the effective dose 
of a drug or the evaluation of the response to a particular treatment. PET has also become 
an essential tool among the basic and medical research communities, by enabling the non-
invasive and translational investigation of a wide variety of biological, physiological and 
pathological phenomena.   
Emerging PET applications, together with the need for better, more efficient and even 
personalized diagnostic tools, have resulted in a boost in the demand for new molecular 
probes for biological targets currently unavailable to this technique. The development of 
such molecular probes (radiotracers) requires a multidisciplinary approach, which should 
start at target identification, structure design, and development/implementation of 
labelling strategies, followed by exhaustive in vitro and in vivo testing, ultimately leading 
to radiotracer characterization. This PhD is framed mainly in the context of developing 
novel radiolabelling strategies.  
1.2.2. PET isotopes 
Only certain radionuclides have appropriate physical properties to become suitable 
candidates for the preparation of radiotracers. In the particular case of positron emitters, 
there are four radioisotopes which have been historically used: carbon-11, nitrogen-13, 
fluorine-18 and oxygen-15. The wide historical use of these isotopes is due to a 
combination of different factors, including: (i) they can be produced in relatively high 
yields in commercially available biomedical cyclotrons; (ii) their decay mode is close to 
100% positron emission; (iii) they can be easily introduced in biomolecules, and (iv) their 
stable isotopes are present in all organic molecules. Of course, this is not the case for 
fluorine-18. However, the substitution of a hydroxyl group or hydrogen atom by a fluorine 
atom may not dramatically alter the biological behaviour of the resulting molecule.  
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Among these four radionuclides, fluorine-18 has been the most widely used, especially for 
clinical applications. Fluorine-18 forms strong covalent bonds with carbon atoms and can 
be incorporated into a large variety of organic molecules. Moreover, fluorine-18 has a 
small positron range and its half-life (110 min) allows for the preparation of complex 
molecules with acceptable radiochemical yields, as well as the centralised production of 
radiotracers and distribution to satellite centres.  
Out of the above mentioned clinical environment, other positron emitters such as carbon-
11 and nitrogen-13 have a huge potential for the synthesis of radiotracers. The 
preparation of radiotracers with these two radionuclides is far from trivial due to their 
short half-life (20.4 and 9.98 min, respectively). Carbon-11 can be obtained in cyclotrons 
in different chemical forms: [11C]CO2 (obtained by proton irradiation of N2/O2 gas 
mixtures) and [11C]CH4 (obtained by irradiation of  N2/H2 mixtures). On the other hand, 
nitrogen-13 is obtained by irradiation of water solutions and is usually produced as 
[13N]NH4+ after irradiation of diluted ethanol aqueous solutions; this radiochemical specie 
has direct application in the clinical environment as perfusion marker. Oxygen-15 is the 
shortest-lived positron emitting isotope of oxygen. Its half-life is close to 2 minutes, and 
hence it is mainly used as produced [15O]O2 or for the preparation of [15O]H2O. 
The main drawback of the above-mentioned radionuclides is their short half-lives, which 
limit the duration of the in vivo investigations to a maximum of ca. a few hours in the case 
of Fluorine-18 and less than 2 hours in the case of 11C and 13N. Recently, other longer-lived 
positron emitters have gained attention, including copper-64 and zirconium-89 (half-lives 
of 12.7 and 78.4 h, respectively), which have been widely used for the preparation of 
labelled peptides, macromolecules (proteins, antibodies) and nanoparticles. Gallium-68, a 
68 min half-lived positron emitter, has also gained relevance because it can be easily 
obtained from commercially available 68Ge/68Ga generators. 
This PhD thesis is framed in the use of nitrogen-13 and the development of innovative 
radiolabelling strategies concerning this radionuclide. Because of this, an overview of the 
13N-radiochemistry developed to date will be included in this introductory chapter. The 
radiochemistry of other commonly used positron emitters such as fluorine-18 or carbon-
11 has been widely reviewed in the literature (see for example [2, 3]).  
1.3. NITROGEN-13 
With a half-life of 9.97 min, nitrogen-13 was one of the first positron emitters to be 
produced, and was discovered in 1934 by F. Joliot and I. Joliot-Curie [4], who irradiated 
boron nitride with α particles and produced 13N via the 10B(α,n)13N nuclear reaction. The 
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authors reported that “our latest experiments have shown a very striking fact: when an 
aluminium foil is irradiated on a polonium preparation, the emission of positrons does not 
cease immediately, when the active preparation is removed. The foil remains radioactive and 
the emission of radiation decays exponentially as for an ordinary radio-element. We observed 
the same phenomenon with boron and magnesium. The half life period of the activity is 14 
min. for boron, 2 min. 30 sec. for magnesium, 3 min. 15 sec. for aluminium”. When the 
irradiated boron nitride was treated with sodium hydroxide, a gas was generated. This 
gas, in contact with a paper soaked in hydrochloric acid, produced a radioactive white 
deposit which was identified as NH4Cl. Joliot and Curie were awarded with the Nobel Prize 
in 1935 “for their synthesis of new radioactive elements”. In the same year, alternative 
routes for the production of 13N, based on the irradiation of 13C-enriched graphite with 
protons and by irradiation of natural graphite with deuterons, were reported by J. 
Cockcroft, C. W. Gilbert and E. T. S. Walton [5]. 
1.3.1. Production of nitrogen-13 
After the pioneering works by Joliot and Curie, several routes for the production of 13N by 
proton, deuteron or neutron irradiation of stable materials have been developed (see table 
1.2). Mainly, 3 nuclear reactions using accelerated ions can be utilized: 12C(d,n)13N, 
13C(p,n)13N and 16O(p,α)13N. In addition, irradiation of natural nitrogen (14N) with neutrons 
also produces 13N via an (n,2n) reaction. The nuclear reaction 16O(p,α) 13N is by far the 
most commonly utilized nowadays. However, by modification of the incident particle and 
chemical and physical forms of the irradiated material, different 13N-labelled species can 
be produced. 
Table 1.2: Methods for the production of 13N using nuclear reactions.   
Target material Nuclear reaction In-target product 
CO
2
 (trace N
2
) 12C(d,n)
13
N [
13
N]N
2
 
Graphite 12C(d,n)
13
N [
13
N]CN 
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13
N [
13
N]N
2
 + trapped [
13
N]CN 
13
C-enriched charcoal 
13
C(p,n)
13
N Trapped [
13
N]CN 
H
2
O / ethanol 16O(p,α)
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N [
13
N]NH
3
 
H
2
O 16O(p,α)
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N [
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N]NH
3
 + [
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N]NO
3
-
 +  [
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N]NO
2
-
 
NaNO
3
 (aq) 14N(n,2n)
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N [
13
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3
 
Al
4
C
3
 12C(d,n)
13
N Matrix trapped 
13
N 
CH
4
 (flowing) 12C(d,n)
13
N [
13
N]NH
3
 +  [
13
N]HCN + [
13
N]CH
3
NH
2
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It was early discovered that irradiation of pure water with high energy protons results in 
the formation of [13N]NO3-, and the formation of this species increases with increased 
target dose due to radiolytic oxidations [6].  Such irradiation is generally carried out in 
liquid targets (see Figure 1.4 for general scheme of a typical target configuration).  
 
Figure 1.4. Typical target design for the production of [13N]NH3 by irradiation of 5mM ethanol 
aqueous solution with protons, based on the target Nirta® Liquid provided by IBA Molecular. 
However, the presence of minor amounts of [13N]NO2 and [13N]NH4+ could be also detected. 
A few years later, Wieland and co-workers realized that the addition of scavengers to the 
irradiated water modified the percentage of the different 13N-labelled species ([13N]NO3-, 
[13N]NH4+, [13N]NO2-, and [13N]2) [7]. For example, addition of 5mM ethanol to the target 
resulted in >96% of the radioactivity as [13N]NH3, irrespective of the beam intensity (15-
30 μA), and similar results were obtained after addition of acetic acid. The mechanisms 
behind this experimental finding are not well understood, although it is thought to be due 
to prevention of radiolytic oxidation due to the presence of the scavenger. Irradiation of 
solid water (ice) [8], and pressurization of the target with hydrogen [9-11] and methane 
[12] also prevent radiolytic oxidation and result in preferential formation of [13N]NH3.    
1.3.2. Radiochemistry of nitrogen-13 using [13N]NH3 as the labelling agent 
1.3.2.1. Radiosynthesis of amino acids 
Nitrogen-13 has been widely exploited in the preparation of 13N-labelled amino acids, 
mainly during the 70’s and 80’s, most of them with the ultimate goal to investigate protein 
synthesis rates, particularly in tumours. Chemical methods for the preparation of 13N-
labelled amino acids are usually time-consuming and inefficient, lead to the formation of 
BEAM
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intermediate compounds and yield racemic mixtures. Consequently, only a few examples 
have been reported in the literature. Just to mention one, in 1979 the synthesis of L-
[13N]aspargine by reaction of L-α-N-Boc-aspartate with [13N]NH3 and further hydrolysis 
was reported by Elmalech and co-workers [13] (Figure 1.5).  
 
Figure 1.5. Synthesis of L-[13N]aspargine by a synthetic chemistry method. 
Comparatively, biosynthetic methods using enzymes are rapid and yield the 
enantiomerically pure compounds. Therefore, these are usually anticipated to be more 
convenient. Several attempts have been carried out to synthesize labelled amino acids 
using enzymes. The general approach consists of incubating [13N]NH3 with the appropriate 
precursor and the enzyme (with cofactors) in buffered aqueous solution. Under these 
conditions, L-[13N] glutamate was rapidly synthesized by incubation of [13N]NH3 with α-
ketoglutarate in the presence of L-glutamate dehydrogenase as the enzyme, which 
catalyses the reductive amination of alpha-keto acids to amino acids, and NADPH 
(nicotinamide adenine dinucleotide phosphate) as cofactor in phosphate buffer (Figure 
1.6a) [14]. Removal of unreacted [13N]NH3 was carried out by boiling the crude reaction 
mixture and filtered to yield 8mCi (296 MBq) of L-[13N] glutamate (radiochemical yield = 
15%).  
OH
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Figure 1.6. Synthesis of L-[13N]glutamate (a) and L-[13N]glutamine (b) via biosynthetic routes. 
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By using a parallel strategy, L-[13N]glutamine was synthesized by incubation at of [13N]NH3 
with glutamic acid and glutamine synthetase as the enzyme in the presence of cysteine and 
adenosine triphosphate and magnesium sulphate as cofactors (Figure 1.6b) [15].   
In 1973, Straatman and Welch demonstrated the feasibility of utilizing glutamate 
dehydrogenase to introduce 13N into amino acids other than glutamate by synthesizing L-
[13N]valine, L-[13N]alanine and L-[13N]leucine from the corresponding α-keto acids and 
[13N]ammonia with decay-corrected yields ranging from 6.8% to 26% [16].  
The above mentioned method for the preparation of labelled amino acids is extremely 
convenient. However, contamination of the final tracer with enzymes may pose problems 
for putative human applications. A purification method based on column chromatography 
was attempted for the synthesis of L-[13N]glutamic acid and L-[13N]alanine [17]. However, 
because of the short half-life of 13N, application of pressure was required to achieve rapid 
purification; this resulted in suboptimal results and the presence of enzyme in the final 
product could be detected. To overcome this drawback, an alternative synthetic strategy 
based on the use of ‘immobilized enzymes’ (enzymes that are synthetically attached to a 
water-insoluble support by either physical or chemical means) was developed. The 
preparation of L-[13N]glutamic acid and L-[13N]alanine were carried out by using this 
strategy (Figure 1.7) [17]. Using similar strategies, the preparation of L-[13N]glutamic acid 
could be achieved by using immobilization of the enzyme (glutamic acid dehydrogenase) 
on an activated CNBr-Sepharose support [18], and the same support was successfully 
applied to the synthesis of the branched-chain L-amino acids L-[13N]valine and L-
[13N]leucine [19], as well as other amino acids such as L-[13N]alanine, L-α-
[13N]aminobutirate or L-[13N]methionine [20].  
 
Figure 1.7. Synthesis of L-[13N]glutamate and L-[13N]alanine using immobilized enzymes. 
Very recently, the one-pot, enzymatic and non-carrier-added synthesis of the 13N-labelled 
amino acids L-[13N]alanine, [13N]glycine, and L-[13N]serine by using L-alanine 
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dehydrogenase from Bacillus subtilis, an enzyme that catalyses the reductive amination of 
α-keto acids by using nicotinamide adenine dinucleotide (NADH) as the redox cofactor and 
ammonia as the amine source, has been reported by our research group [21]. 
Interestingly, the integration of both L-alanine dehydrogenase and formate 
dehydrogenase from Candida boidinii in the same reaction vessel to facilitate the in situ 
regeneration of NADH during the radiochemical synthesis of the amino acids allowed a 50-
fold decrease in the concentration of the cofactor without compromising reaction yields.  
1.3.2.2. Radiosynthesis of amines and amides 
Amines and amides can be synthesised by using different synthetic methods. The 
synthesis of 13N-labelled amines has been achieved via Hoffman rearrangement [22] 
(Figure 1.8a), reduction of amides [23] (Figure 1.8b), reduction of imines [24] (Figure 1.9), 
and by using amination of organoboranes [25]. The latter could be optimized by using 
polymeric borane reagents (Figure 1.10). Ammonolysis of halo-substrates has been also 
employed in the preparation of [13N]adenosine.  
 
Figure 1.8. Synthesis of 13N-labeled β-phenethylamine via Hofmann rearrangement (a) and 
reduction of the amide (b). 
 
 
Figure 1.9. Synthesis of [13N]amphetamine via formation of the imine. 
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Figure 1.10. Synthesis of [13N]amines using polymeric borane reagents. 
13N-labelled amides have been prepared as intermediates for the preparation of amines 
via Hoffman rearrangement (see Figure 1.8a).  
1.3.2.3. Radiosynthesis of other compounds 
[13N]ammonia has been used for the preparation of different labelled compounds that do 
not fall into one of the above mentioned categories. There are only a few examples 
described in the literature and because of this, they have been grouped into this section.  
One of the most remarkable examples is the preparation of the well know compound cis-
platin, which was prepared in a multi-step process [26]. First, K2PtCl4 was reacted with 
potassium iodide to yield K2PtI4, which was further treated with carrier-added [13N]NH3 to 
form cis-Pt([13N]NH3)2I2. After addition of AgNO3 and filtering, cis-Pt([13N]NH3)2Cl2 could 
be obtained in 27.1% decay-corrected radiochemical yield. The method was then 
improved by directly sparging [13N]NH3 into K2PtI4  [27].  
Other families of compounds have been prepared form the labelling agent [13N]NH3. For 
example, the opioid tetrapeptide H-Tyr-D-Met(O)-Phe-Gly-[13N]NH2 (SD-62) could be 
synthesized by amination reaction of its activated p-nitrophenol ester with anhydrous 
[13N]NH3 [28].  
In 1977, Krizek and co-workers developed a method for preaparation of [13N]urea by 
boiling [13N]NH3 in the presence of ammonium cyanate [29]. After purification of the 
reaction mixture with ion exchange resin [13N]urea could be obtained in decay-corrected 
radiochemical yield of 56% in 10 min. By using a parallel approach, the one-pot synthesis 
of [13N]urea and [13N]carbamate analogues by using anhydrous [13N]NH3 under non-
carrier added conditions was reported by kumata [30].  In this approach, a primary amine, 
a secondary amine or an alcohol were treated with triphosgene to yield the intermediate 
isocyanate, carbamoyl chloride or chloroformate, respectively; these were further reacted 
with [13N]NH3 to yield the corresponding [13N]urea and [13N]carbamate analogues (Figure 
1.11). [13N]NH3 was also recently used by the same group to approach the preparation of 
CHAPTER 1: Introduction 
13 
 
[13N]thalidomide (Figure 1.12) [31], which could be achieved by reaction of N-
phthaloylglutamic anhydride with [13N]NH3, followed by cyclization using 
carbonyldiimidazole. The preparation of [13N]dantrolene was also reported by the same 
research group [32]. 
  
Figure 1.11. One-pot synthesis of [13N]urea (a) and [13N]carbamate (b, c) analogues using non 
carrier added [13N]NH3. 
 
Figure 1.12. Synthesis of [13N]thalidomide using non carrier added [13N]NH3. 
1.3.3. Radiochemistry of nitrogen-13 using [13N]NO2- as the labelling agent 
This PhD has focused on the development of innovative strategies for the preparation of 
13N-labelled compounds starting from the labelling agent [13N]NO2-, which was obtained 
after reduction of cyclotron produced  [13N]NO3-. Such labelling agent has been previously 
used by other research groups and by us for the preparation of different labelled 
molecules. The most relevant examples are included below.   
1.3.3.1. Radiosynthesis of [13N]nitroso compounds  
One of the first examples found in the literature include the preparation of 
[13N]nitrosamines and [13N]nitrosothiols, which were first reported by Vavrek and 
Mulholland [33]. The reduction of cyclotron produced [13N]NO3- was achieved using an 
activated cadmium column and the nitrosation reaction was conducted on thiols and 
secondary amines in an anion exchange resin after selective trapping of the reduced 
species [13N]NO2-. Based on this method, our group developed some years ago a fast and 
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simple strategy for production of 13N-labelled nitroso-glutathione ([13N]GSNO) via the 
radio-nitrosation of GSH [34] (Figure 1.13). The formation of the desired product could be 
achieved with overall radiochemical yield above 20%. The same methodology was later on 
further expanded and applied to the preparation of other 13N-labeled nitrosothiols using 
conventional chemistry [35] and microfluidics chemistry [36]. In the latter case, as 
expected, higher yields could be obtained under equivalent experimental conditions. The 
nitrosation reaction was also applied by our research group to the preparation of 13N-
labeled nitrosamines [37]. In this particular case, low yields were obtained probably due 
to the low nucleophilic character of secondary amines when compared to thiols. Hence, a 
pre-activation step by treatment with Ph3P/Br2 was required (Figure 1.14), and four 
different 13N-nitrosamines could be obtained with acceptable radiochemical yields. 
 
Figure 1.13. Synthesis of [13N]GSNO. 
 
Figure 1.14. Activation of amines for subsequent production of 13N-labelled nitrosamines. 
1.3.3.2. Radiosynthesis of [13N]azo compounds  
The use of the labelling agent [13N]NO2- has been recently used by our research group for 
the preparation of 13N-labeled azo compounds [38], using a two-step synthetic route. First, 
[13N]NO2- was reacted with aromatic primary amines to generate the corresponding 13N-
labeled diazonium salts, which were subsequently reacted with aromatic amines or 
phenols. In a posterior work, a library of compounds was synthesized and the resulting 
labelled azo compounds were assayed as β-Amyloid markers in a mouse model of 
Alzheimer disease [39] (see Table 1.3). Selective accumulation of the 13N-labelled azo 
derivatives 2, 3 and 5 (Table 1.3) could be detected in Tg2576 mice brain regions with 
high plaque load. Among these three radiotracers, compounds 2 and 3 showed good in vivo 
performance in PET assays (see Figure 1.15 for example of images).  
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Figure 1.15. (a-d) PET images obtained with [
Tg2576 and wild type (WT) animals;
after administration of compounds 1 (e) and 3 (f) in transgenic (Tg2576) and 
animals.  
1.4. CONSIDERATIONS ABOUT NITROGEN
Nitrogen-13 has been historically “forgotten” as a useful radionuclide
of complex structures. Indeed, there are several limitations in its use both in the pre
clinical and clinical settings. Because of this, o
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the development of new strategies for the preparation of 13N-labelled compounds. The 
major limitation of this radionuclide is its short half-life, which poses three main 
difficulties: (i) its use is restricted to those clinical and research organizations with access 
to a cyclotron. Nitrogen-13 has to be produced and used on site, and distribution from 
centralized production centres to surrounding facilities is unfeasible; (ii) because of this 
short half-life, extremely rapid and efficient methods have to be applied to the preparation 
of 13N-labelled radiotracers, to prevent significant decay-associated radioactivity loss; and 
(iii) even when the preparation of the radiotracer is feasible, the amount of radioactivity 
has to be sufficient for subsequent imaging studies; additionally, the biological half-life of 
the radiotracer should match the physical half-life of the isotope. In other words, nitrogen-
13 can be only used to investigate fast in vivo processes. Besides the short half-life, 
nitrogen-13 has a high positron emission energy, which ultimately results in a high 
positron range (especially compared to e.g. fluorine-18). As a result, lower resolution 
images are obtained, and this can be critical in the case of imaging studies involving small 
rodents such as mice and rats.  
It is worth mentioning that nitrogen-13 has also positive aspects. First, the stable isotopes 
of nitrogen (14N and 15N) are present in the majority of biological active molecules. This 
means that any biological molecule, a priori, can be labelled with nitrogen-13 in order to 
have a radiotracer with a chemical structure which is identical to that of the molecule to be 
investigated. Hence, incorporation of nitrogen-13 to the toolbox of PET chemists may 
provide unique opportunities to achieve labelling of molecules of interest in different 
positions, which may help in understanding certain aspects of in vivo behaviour, for 
example metabolism. Additionally, due to the short half-life of the radionuclide, repeated 
studies may be performed on the same individual within a short period of time and the 
radiation dose posed on the subject under investigation is minor when compared to 
longer-lived radionuclides.  
The above mentioned inconveniences (i) and (ii) might be overcome in the next future. 
First, there is a growing interest in the development of a new generation of smaller (and 
hopefully cheaper and with lower investment requirements) cyclotrons. If this happens, 
more research centres might have access to their own a particle accelerator, facilitating 
the progressive implementation of a “dose on demand” PET scenario. Hence, short-lived 
isotopes may gain relevance. Such small cyclotrons will have particle energy limitations, 
which may hamper the production of nitrogen-13 using liquid targets and the 16O(p,α)13N 
nuclear reaction. This nuclear reaction requires proton energies above 10 MeV to obtain 
significant amounts of radioactivity (see Figure 1.16 for activation function). However, 
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lower proton energies can be used to successfully produce nitrogen-13 when the 13C(p, 
n)13N nuclear reaction is used (see Figure 1.17). In this case, irradiation of powder is 
required, and hence the development of new cyclotrons has to be paralleled by the 
development of easy to operate solid targets.      
 
Figure 1.16. Excitation function for the 16O(p,α)13N nuclear reaction. Obtained from [40].  
 
Figure 1.17. Excitation function for the 13C(p,n)13N nuclear reaction. Obtained from [40].  
The use of nitrogen-13 can also benefit from recent developments in the field of 
microfluidics. Under microfluidics conditions, more efficient incorporation of the 
radioisotope can be achieved in short times. This technology has been applied to the 
preparation of 18F- [41-43], 11C-[44, 45], and 13N-labelled compounds [36] with promising 
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results. Although the real application of microfluidics to the preparation of labelled 
compounds under Good Manufacturing Practices (GMP) and in sufficient quantity to 
approach in vivo experiments in humans needs still further development, realistic 
expectancies have been created and future improvement is quite likely.    
The above mentioned problem (iii) is probably the most challenging. Due to the short half-
life of the radionuclide, exploration of long-lasting biological phenomena with 13N-labelled 
molecules is not possible. However, literature data demonstrates that 60 minutes image 
acquisition is sufficient in many occasions to get very interesting information. For 
example, our research group demonstrated that 13N-labelled nanoparticles can provide 
relevant information about initial biodistribution [46]. In this work, a clear relationship 
between particle size and accumulation in major organs could be observed in very short 
image acquisition times (Figure 1.18). 
 
Figure 1.18. A-D: PET images of different sized 13N-labeled Al2O3 NPs signal at t=60 min. 
Computerised tomography (CT) images were adjusted along the Y axis for an appropriate fitting 
with the tracer distribution image; E: organ accumulation as a function of particle size, according to 
colour codes depicted in F; F: particle size distribution; gray colour in E indicates low accumulation 
irrespective of particle size.  
Taking into account all these issues, it is expected that the use of 13N-labelled compounds 
will increase in the future and synthetic approaches which have been unexplored to date 
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will be investigated. Efficient strategies that were widely used in the past (e.g., enzymatic 
synthesis) might be revived considering the new technologies and possibilities of 
automation, as well as the novel tools for characterization of macromolecules. Dual 
labelling to gain additional information related to the short term metabolism of newly 
developed compounds might also become an interesting tool in research centres and to 
pharmaceutical industry. Hence, the results obtained within the frame of this PhD thesis 
might become very useful for the scientific community in the near future. 
1.5. REFERENCES 
1. Pérez-Campaña, C., Direct activation of metal oxide nanoparticles: application to 
biodistribution studies using positron emission tomography, in Organic Chemistry I, 
2014, UPV/EHU. p. 130. 
2. Miller, P.W., et al., Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission 
tomography. Angewandte Chemie - International Edition, 2008. 47(47): p. 8998-
9033. 
3. Itsenko, O., et al., On 11C chemistry reviews - surveying and filling the gaps. Current 
Organic Chemistry, 2013. 17(19): p. 2067-2096. 
4. Joliot, F. and I. Curie, Artificial production of a new kind of radio-element. Nature, 
1934. 133(3354): p. 201-202. 
5. Cockcroft, J.D., C.W. Gilbert, and E.T.S. Walton, Production of induced radioactivity 
by high velocity protons. Nature, 1934. 133(3357): p. 328. 
6. Parks, N.J. and K.A. Krohn, The synthesis of 13N-labeled ammonia, dinitrogen, nitrite, 
and nitrate using a single cyclotron target system. The International Journal Of 
Applied Radiation And Isotopes, 1978. 29(12): p. 754-757. 
7. Wieland, B., et al., In-target production of [13N]ammonia via proton irradiation of 
dilute aqueous ethanol and acetic acid mixtures. International Journal of Radiation 
Applications and Instrumentation, 1991. 42(11): p. 1095-1098. 
8. Firouzbakht, M.L., et al., Mechanism of nitrogen-13-labeled ammonia formation in a 
cryogenic water target. Nuclear medicine and biology, 1999. 26(4): p. 437-441. 
9. Mulholland, G.K., M.R. Kilbourn, and J.J. Moskwa, Direct simultaneous production of 
[15O]water and [13N]ammonia or [18F]fluoride ion by 26 MeV proton irradiation of a 
double chamber water target. International Journal of Radiation Applications and 
Instrumentation, 1990. 41(12): p. 1193-1199. 
10. Korsakov, M.V., R.N. Krasikova, and O.S. Fedorova, Production of high yield 
[13N]ammonia by proton irradiation from pressurized aqueous solutions. Journal of 
Radioanalytical and Nuclear Chemistry, 1996. 204(2): p. 231-239. 
CHAPTER 1: Introduction 
20 
 
11. Berridge, M.S. and B.J. Landmeier, In-target production of [13N]ammonia: Target 
design, products, and operating parameters. Applied Radiation and Isotopes, 1993. 
44(12): p. 1433-1441. 
12. Krasikova, R.N., et al., Improved [13N]ammonia yield from the proton irradiation of 
water using methane gas. Applied Radiation and Isotopes, 1999. 51(4): p. 395-401. 
13. Elmaleh, D.R., D.J. Hnatowich, and S. Kulprathipanja, A novel synthesis of 13N-L-
asparagine. Journal of Labelled Compounds and Radiopharmaceuticals, 1979. 
16(1): p. 92-93. 
14. Lembares, N., et al., Rapid Enzymatic Synthesis of 10-Min 13N-glutamate and Its 
Pancreatic Localization. Journal of Nuclear Medicine, 1972. 13(10): p. 1. 
15. Cohen, M.B., et al., Enzymatic Synthesis of 13N L-Glutamine. journal of Nuclear 
Medicine, 1972. 13(6): p. 1. 
16. Straatmann, M.G. and M.J. Welch, Enzymatic synthesis of nitrogen 13 labeled amino 
acids. Radiation Research, 1973. 56(1): p. 48-56. 
17. Cohen, M.B., et al., Immobilized enzymes in the production of radiopharmaceutically 
pure amino acids labeled with 13N. Journal of Nuclear Medicine, 1974. 15(12): p. 
1192-1195. 
18. Gelbard, A.S., et al., Imaging of the human heart after administration of L-(N-
13)glutamate. Journal of Nuclear Medicine, 1980. 21(10): p. 988-991. 
19. Barrio, J.R., et al., Synthesis and myocardial kinetics of N-13 and C-11 labeled 
branched-chain l-amino acids. Journal of Nuclear Medicine, 1983. 24(10): p. 937-
944. 
20. Cooper, A.J.L. and A.S. Gelbard, The use of immobilized glutamate dehydrogenase to 
synthesize 13N-labeled l-amino acids. Analytical Biochemistry, 1981. 111(1): p. 42-
48. 
21. da Silva, E.S., et al., Efficient Enzymatic Preparation of 13N-Labelled Amino Acids: 
Towards Multipurpose Synthetic Systems. Chemistry - A European Journal, 2016. 
22(38): p. 13619-13626. 
22. Tominaga, T., et al., Preparation of 13N-β-phenethylamine. The International Journal 
Of Applied Radiation And Isotopes, 1985. 36(7): p. 555-560. 
23. Tominaga, T., et al., Synthesis of 13N-labelled amines by reduction of 13N-labelled 
amides. International Journal of Radiation Applications and Instrumentation, 1986. 
37(12): p. 1209-1212. 
24. Finn, R.D., D.R. Christman, and A.P. Wolf, A rapid synthesis of nitrogen-13 labelled 
amphetamine. Journal of Labelled Compounds and Radiopharmaceuticals, 1981. 
18(6): p. 909-913. 
CHAPTER 1: Introduction 
21 
 
25. Kothari, P.J., et al., Synthesis of nitrogen-13 labeled alkylamines via amination of 
organoboranes. International Journal of Radiation Applications and 
Instrumentation, 1986. 37(6): p. 469-470. 
26. de Spiegeleer, B., et al., Microscale synthesis of nitrogen-13-labeled cisplatin. Journal 
of Nuclear Medicine, 1986. 27(3): p. 399-403. 
27. Ginos, J.Z., et al., [13N]Cisplatin PET to assess pharmacokinetics of intra-arterial 
versus intravenous chemotherapy for malignant brain tumors. Journal of Nuclear 
Medicine, 1987. 28(12): p. 1844-1852. 
28. Saji, H., et al., Synthesis and biological evaluation of a 13N-labeled opioid peptide. 
International Journal of Radiation Applications and Instrumentation, 1992. 19(4): 
p. 455-460. 
29. Krizek, H., P.V. Harper, and B. Mock, Adapting the old to new needs: 13N labeled urea. 
Journal of Labelled Compounds and Radiopharmaceuticals, 1977. 13(2): p. 207. 
30. Kumata, K., et al., One-pot radiosynthesis of [13N]urea and [13N] carbamate using no-
carrier-added [13N]NH3. Journal of Labelled Compounds and Radiopharmaceuticals, 
2009. 52(5): p. 166-172. 
31. Kumata, K., et al., Radiosynthesis of 13N-labeled thalidomide using no-carrier-added 
[13N]NH3. Journal of Labelled Compounds and Radiopharmaceuticals, 2010. 53(2): 
p. 53-57. 
32. Kumata, K., et al., Radiosynthesis of [13N]dantrolene, a positron emission tomography 
probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia. 
Bioorganic and Medicinal Chemistry, 2012. 20(1): p. 305-310. 
33. Vavrek, M.T. and G.K. Mulholland, Simple general synthesis of NCA nitrosothiols and 
nitrosamines. Journal of Labelled Compounds and Radiopharmaceuticals, 1995. 
37(0): p. 2. 
34. Llop, J., et al., Synthesis of S-[13N]nitrosoglutathione (13N-GSNO) as a new potential 
PET imaging agent. Applied Radiation and Isotopes, 2009. 67(1): p. 95-99. 
35. Gómez-Vallejo, V., et al., Fully automated synthesis of 13N-labeled nitrosothiols. 
Tetrahedron Letters, 2010. 51(22): p. 2990-2993. 
36. Gaja, V., et al., Synthesis of 13N-labelled radiotracers by using microfluidic technology. 
Journal of Labelled Compounds and Radiopharmaceuticals, 2012. 55(9): p. 332-
338. 
37. Gómez-Vallejo, V., et al., Efficient system for the preparation of [13N]labeled 
nitrosamines. Bioorganic and Medicinal Chemistry Letters, 2009. 19(7): p. 1913-
1915. 
CHAPTER 1: Introduction 
22 
 
38. Gómez-Vallejo, V., J.I. Borrell, and J. Llop, A convenient synthesis of 13N-labelled azo 
compounds: A new route for the preparation of amyloid imaging PET probes. 
European Journal of Medicinal Chemistry, 2010. 45(11): p. 5318-5323. 
39. Gaja, V., et al., Synthesis and evaluation of 13N-labelled azo compounds for β-amyloid 
imaging in mice. Molecular Imaging and Biology, 2014. 16(4): p. 538-549. 
40. Cyclotron produced radionuclides: Physical characteristics and production methods, 
in Technical reports series nº 4682009, International Atomic Energy Agency: 
Vienna. p. 196-203. 
41. Zheng, M.Q., et al., Synthesis of [18F]FMISO in a flow-through microfluidic reactor: 
Development and clinical application. Nuclear medicine and biology, 2015. 42(6): p. 
578-584. 
42. Javed, M.R., et al., High yield and high specific activity synthesis of [18F]fallypride in a 
batch microfluidic reactor for micro-PET imaging. Chemical Communications, 2014. 
50(10): p. 1192-1194. 
43. Chen, S., et al., Radiolabelling diverse positron emission tomography (PET) tracers 
using a single digital microfluidic reactor chip. Lab on a Chip - Miniaturisation for 
Chemistry and Biology, 2014. 14(5): p. 902-910. 
44. Dahl, K., et al., 11C-carbonylation reactions using gas-liquid segmented microfluidics. 
RSC Advances, 2015. 5(108): p. 88886-88889. 
45. Ungersboeck, J., et al., Optimization of [11C]DASB-synthesis: Vessel-based and flow-
through microreactor methods. Applied Radiation and Isotopes, 2012. 70(11): p. 
2615-2620. 
46. Pérez-Campaña, C., et al., Biodistribution of different sized nanoparticles assessed by 
positron emission tomography: A general strategy for direct activation of metal oxide 
particles. ACS Nano, 2013. 7(4): p. 3498-3505. 
 
 
  
 
 
 
 
 
 
 
 
2. Justification and Objectives 
  
 
CHAPTER 2: Justification and objectives 
25 
 
2. JUSTIFICATION AND OBJECTIVES  
2.1. JUSTIFICATION 
Emerging PET applications, together with the need for better, more efficient and even 
personalized diagnostic tools, have resulted in a boost in the demand for new molecular 
probes for biological targets currently inaccessible to this technique. The development of 
such molecular probes (radiotracers) requires a multidisciplinary vision and approach, 
which should start at target identification, structure design and development / 
implementation of radiolabelling strategies, followed by exhaustive in vitro and in vivo 
testing, ultimately leading to radiotracer validation. 
The radiochemistry associated with the synthesis of radiotracers is far from trivial, 
especially for short half-lived radionuclides. Because of the limited availability of training 
programs in this field, PET centres and (radio)pharmaceutical companies compete for a 
limited pool of talent. This gap was identified by Prof. V. Gouverneur (University of 
Oxford), coordinator of the Marie-Curie FP7-PEOPLE-ITN action RADIOMI (2012-2016). In 
this initiative, six academic (University of Oxford in UK, King’s College London in UK, 
University of Turku in Finland, VU University Medical Center in Amsterdam, Medical & 
Health Science Center in Debrecen, University Claude Bernard in Lyon and CIC 
biomaGUNE in San Sebastian) and two industrial partners (Advanced Accelerator 
Applications and GE Healthcare), all of them leading experts in the areas of chemistry and 
radiochemistry, pooled their expertises to implement a coordinated, first-class training 
program to produce new talent in PET radiochemistry, focused on the development of 
innovative radiolabelling strategies for the preparation of small molecules labelled with 
short-lived positron emitters, namely fluorine-18, carbon-11 and nitrogen-13, while 
spanning over a wide range of molecular formats. Besides establishing a cutting-edge, 
scientifically sound research program, this successful initiative aimed to provide 
transnational and cross-sectorial training to 15 ESRs and 3 ERs, covering different aspects 
of radiolabelling using positron emitters.  
CIC biomaGUNE, a research institution located in San Sebastian and where the 
experimental part of the current PhD thesis was conducted, participated in such initiative. 
Due to the previous work and tracked experience of Dr. Llop’s group in the field of 13N-
radiochemistry, the specific role of CIC biomaGUNE team within the project was to 
develop innovative labelling strategies using nitrogen-13. With that aim, two PhD students 
were selected. One of them, Eunice S. Da Silva, was focussed on developing innovative 
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enzymatic strategies for the preparation of radiolabelled amino acids. The project for the 
second PhD student, myself, Sameer M. Joshi, author of the work presented here, should 
focus on the development of novel strategies for the preparation of 13N-labelled 
compounds using the labelling agent [13N]NO2-. Besides conducting the experimental work 
and getting involved in a cutting-edge research program at the local level, participation in 
the RADIOMI Initiative provided the opportunity to perform one stay at University of 
Oxford under the supervision of Prof. V. Gouverneur and a short stay at King’s College 
London under the supervision of Prof. A. D. Gee, and to attend periodic meetings and 
different workshops, schools and international conferences, which have contributed to my 
overall education.   
In this context, the first main goal of the current PhD was to develop strategies for the 
preparation of 13N-labelled azides, which can be used as suitable building blocks for the 
subsequent preparation of more complex molecules. For this, a methodology for the 
preparation of 13N-labelled azides was first implemented. Execution of the experimental 
part led to surprising results and because of this, certain mechanistic aspects of the 
synthesis of azides were investigated using 13N-radiolabelling together with 
computational studies, which were performed in collaboration with the group of Prof. 
Fernando Cossío (UPV-EHU). It is worth mentioning that the use of 13N-radiochemistry to 
investigate mechanistic aspects of reactions is unprecedented. The results obtained were 
published in Chemical Communications (see ref. [1]) and are the basis of chapter 3 of this 
PhD. 
The knowledge gained during this first work was then applied to the development of 
suitable strategies for the preparation of 13N-labelled triazoles using (3+2) Huisgen 
cycloaddition between labelled aromatic azides and alkynes. A small library of compounds 
could be prepared, including one molecule with potential application as β-amyloid marker. 
The synthetic process for the preparation of this compound was fully automated. 
Moreover, the methodology was expanded to the formation of triazoles via reaction of 
labelled azides with aldehydes. This work, which is the basis of chapter 4 of the current 
PhD thesis, was published in RSC Advances (see ref. [2]).       
The third experimental part of the PhD thesis consisted of developing innovative 
radiolabelling strategies for the preparation of 13N-labelled tetrazoles via (3+2) Huisgen 
cycloadditions. These reactions proceed slowly, and hence the first part of this work 
consisted of developing inorganic, nanostructured, copper-based heterogeneous catalysts 
in collaboration with Dr. Chandrashekhar V. Rode (Chemical Engineering & Process 
Development Division, National Chemical Laboratory, Pune, India). These catalyst were 
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first tested in cold (non radioactive) conditions. After optimization of the experimental 
conditions and selection of the best catalyst, the experimental set up was then applied to 
the synthesis of labelled tetrazoles. Most of the experimental work was performed in CIC 
biomaGUNE, San Sebastain, Spain. However, the copper based heterogeneous catalysts 
reported in this chapter were synthesized in NCL, India. The manuscript has been 
prepared and has been submitted to a scientific journal (New Journal of Chemistry) for 
consideration for publication. 
2.2. OBJECTIVES 
As mentioned above, the general objective of this PhD thesis was the development of 
labelling strategies for the preparation of novel 13N-labelled radiotracers. To achieve this 
ambitious goal, the following specific objectives were defined: 
1- To develop fast and efficient strategies for the synthesis, purification and 
characterization of 13N-labelled aromatic azides. 
2- To investigate mechanistic aspects about the formation of aromatic azides using 13N-
labelling and computational methods.  
3- To apply the results obtained in objectives (1) and (2) to develop efficient strategies 
for the preparation of 13N-labelled triazoles using (3+2) cycloaddition with alkynes 
and aldehydes. 
4- To implement a fully automated process for the production (synthesis, purification 
and formulation) of selected 13N-labelled triazoles. 
5- To develop novel nanostructured copper based hetrogeneous catalysts for the efficient 
production of tetrazoles.  
6- To apply the most promising catalysts from objective (5) to the preparation of 13N-
labelled tetrazoles.   
2.3. REFERENCES 
1. Joshi, S.M., et al., Synthesis of radiolabelled aryl azides from diazonium salts: 
Experimental and computational results permit the identification of the preferred 
mechanism. Chemical Communications, 2015. 51(43): p. 8954-8957. 
2. Joshi, S.M., et al., Synthesis of 13N-labelled polysubstituted triazoles: Via Huisgen 
cycloaddition. RSC Advances, 2016. 6(111): p. 109633-109638. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
3. Synthesis of 13N-labelled azides 
 
 
 
 
  
 
CHAPTER 3: Synthesis of 13N-labelled azides 
31 
 
3. SYNTHESIS OF 13N-LABELLED AZIDES 
3.1. INTRODUCTION 
Azide is an anion which contains three nitrogen atoms with the basic formula N3- (Figure 
3.1a). The azide functional group can be represented by two resonance structures (Figure 
3.1b). From a wide perspective, azides can be classified in to two main groups: organic and 
inorganic azides. Azides are energy-rich molecules with many applications; however, it is 
worth mentioning that both organic and inorganic azides can be heat- and shock-sensitive 
and can explosively decompose with a small input of external energy; hence, extreme 
precaution is required while handling azides. 
 
 
Figure 3.1.  a) Basic formula of azide anion; b) resonance structures of azides. 
3.1.1. Inorganic azides 
Inorganic azides can be prepared from sodium azide, which is an inorganic compound 
with formula NaN3. Sodium azide, which under normal conditions is an ionic solid which 
exists in two crystalline forms (rhombohedral and hexagonal, [1]) is industrially prepared 
from metallic sodium and ammonia to form the sodium amine, which in a second step is 
reacted with nitrous oxide to produce sodium azide, ammonia and sodium hydroxide. An 
alternative production process better suited for laboratory application was developed by 
Curtius and Thiele [2-4]. In this process, a nitrite ester is converted into sodium azide 
using hydrazine.   
3.1.2. Organic azides 
Organic azides are considered as powerful precursors for reactive species such as nitrenes 
and nitrenium ions as well as nitrogen-rich compounds such as aziridines, azirines, 
triazoles, triazolines and triazenes. Moreover, organic azides can be easily transformed 
into amines, isocyanates and other functional molecules, and recently they have received 
an increasing interest as valuable reagents within the concept of “Click Chemistry”.  
Organic azides can be prepared using different routes. The most important ones are briefly 
introduced in Table 3.1.  
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Table 3.1. Production of organic azides 
Route Scheme 
Reaction of haloarenes with 
sodium azide by nucleophilic 
aromatic substitution reaction [5, 
6]. 
 
Reaction of diazonium salts with 
hydrazine [7, 8]. 
 
Formation of arylazide by reaction 
of  arene diazonium perbromides 
with ammonia [9, 10]. 
 
Dutt-Wormall reaction, in which a 
diazonium salt initially reacts with 
a sulfonamide to form 
diazoaminosulfinate; subsequent 
hydrolysis results in the formation 
of the azide and sulfinic acid [11]. 
 
Aromatic and aliphatic azides, acyl 
azides, and sulfonyl azides can be 
prepared by reaction of hydrazines 
with nitrosyl ions or their 
precursors N2O4 [12, 13].  
 
Clevage of triazenes into azides 
[14]. 
 
Addition of halogen azides to 
olefins. This reaction is a general 
synthetic process for the formation 
of alkenyl azides [15-17].  
 
In 1864, the preparation of the first organic azide (phenyl azide) was reported by Peter 
Grieß. Later on, these azides have become flexible intermediates and have gained 
remarkable interest [18-20]. A few years later Curtius developed a methodology in which 
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alkyl, aryl or acyl chlorides react with sodium azide in an aqueous solution to form acyl 
azides [21, 22] which give isocynates via Curtius rearrangment. Additionally, acyl azide 
can also be prepared by the reaction of acylhydrazines with nitrous acid [13] as well as by 
the reaction of carboxylic acid with diphenylphosphorylazide (DPPA)  [23].  
Table 3.2 Applications of organic azides 
Reactions  Scheme 
[3+2] cycloaddition of organo-
azides with alkynes to give 
triazoles [24].  
 
[3+2] cycloaddition of azides with 
nitriles to give tetrazoles [25]. 
 
 
 
 
Formation of an amidic phosphine 
oxide by Staudinger ligation [26]. 
 
Azidoalkyl-substituted epoxides 
undergoe Schmidt reaction [27]. 
 
Asymmetric synthesis of 2,3-
diamino-3-phenylpropanoic acid 
derivates by using  Mitsunobu 
reaction [28]. 
 
Preparation of pyrazoloisoquino-
line by Aza-Wittig cyclization of a 
formyl group with the azide group 
of a 4-azido-1-(benzyloxy)-5-(2-
formylphenyl)pyrazole [29]. 
 
 
Azide RN3 as a functional group can be used in a wide variety of applications in organic 
chemistry [30] (see Table 3.2). In the 1950s and 1960s, the organic azides received 
considerable attention [14, 31] with new applications in the chemistry of the wide variety 
of azides such as acyl, aryl, and alkyl azides. Organic azides can be used in the preparation 
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of heterocyclic compounds. Also they can be used in synthesis of peptides [32, 33] as well 
as in pharmaceuticals [34]. Among organic azides, aryl azides have relatively high stability 
and therefore, can be used in industrial and biological field [35-37].  
Organic azides can be used more effectively in Huisgen 1,3-dipolar azide-alkyne 
cycloadditions [38] and also can be used for the preparation of anilines, nitrenes and N-
alkyl-substituted anilines [39], and have been employed in the preparation of biologically 
active compounds and in the synthesis of natural products [40, 41]. The number of articles 
reporting on the use of organic azides has continuously increased in the last years. 
Currently, there are more than 1000 publications per year.  
One of the most important applications of organic azides is in the preparation of triazoles 
and tetrazoles by reaction with alkynes [24] and nitriles [25], respectively. They are also 
employed in a wide variety of well known reactions such as Staudinger ligation [26], 
Hemetsberger–Knittel [42], Schmidt [27], Mitsunobu [28] and Wittig (aza- Wittig) 
reactions [29].  
3.2. AIM AND OBJECTIVES 
As mentioned above, organic azides and particularly phenyl azides have many applications 
in organic synthesis. However their use in the preparation of radiolabelled compounds to 
be evaluated in vitro or in vivo by means of nuclear imaging requires the development of 
strategies for the incorporation of positron or gamma emitters. In the research group 
where this PhD was conducted, there is a high interest in the development of novel 
strategies for the synthesis of 13N-labelled compounds. In this context, access to labelled 
aromatic azides would provide access to a versatile tool which might be used in the 
preparation of a wide variety of labelled molecules.  
To date, azides have been labelled with the stable isotope Nitrogen-15 and the label was 
used in the investigation of mechanistic aspects using nuclear magnetic resonance [43]. 
When we first explored in the literature potential routes for the preparation of 13N-
labelled aromatic azides, we first considered the possibility to apply the well known Dutt-
Wormall reaction, which works very well under non-radioactive conditions and is based 
on the basic hydrolysis of aromatic diazoaminosulfinate, which can be easily synthesized 
from aromatic diazonium salt and arylsulfonamide or alkylsulfonamide. This reaction 
offered sub-optimal results under radioactive conditions, because two purification steps 
via liquid-liquid extraction were required; hence other alternatives were pursued. Finally, 
a convenient route based on the reaction of diazonium salts with in situ generated 
hydrazoic acid (by reaction of hydrazine monohydrate with sodium nitrite in acidic media) 
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was found in the literature
irradiation of pure water with high energy protons followed by reduction of the resulting 
species (mainly [13N]NO3-), and (ii) [
diazonium salts and hydrazoic acid, we were in 
approaches could be used for the preparation of labelled aryl azides, schematized in 
Figure 3.2. 
 
Figure 3.2.  The two alternative strategies A and B followed to synthesize 
([13N]2) from 13N-labelled diazonium salt ([
The first approach (A in the Figure) consists of reacting [
monohydrate in acetic acid to yield the corresponding 
is further reacted with the non
azide. The second approach (B in the Figure) consists of reacting [
aromatic amine in acidic media to yield the corresponding 
which is further reacted with non
phenyl azide. In this reaction, nitrogen gas is released as a by
[13N]N2 could be a drawback
the best method, we decided to explore both routes. As a result, the mechanistic study 
presented in this chapter could be conducted.
In this context, the following specific objectives were defined:
1. To develop a synthetic strategy for the preparation of 
Dutt-Wormall reaction.  
3: Synthesis of 13N-labelled azides 
. Considering that (i) [13N]NO2- can be easily achieved by 
13N]NO2- is the precursor for the preparation of both 
the lucky situation that two different 
13N-label
13N]1) in this thesis. 
13N]NO2- 
13N-labelled hydrazoic acid, which 
-labelled diazonium salt to yield the desired labelled phenyl 
13
13N-labelled diazonium salt, 
-labelled hydrazoic acid to yield the desired labelled 
-product, and release of 
 in terms of overall radiochemical yield. In order to achieve 
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2. To develop an optimized synthetic strategy for the preparation of 13N-labelled phenyl 
azides via reaction of diazonium salts with in situ generated hydrazoic acid.  
3. To determine the mechanism of the reaction mentioned in objective 2, with the 
ultimate goal to establish the best radio-synthetic approach.  
4. To proof the mechanism suggested by experimental results using computational 
methods.  
IMPORTANT REMARK: All the experimental work included in this chapter was 
performed in CIC biomaGUNE, San Sebastian, Spain. In order to obtain the evidences about 
the most plausible reaction mechanism and get a better understanding of the experimental 
data, computational calculations were carried out. The Computational work reported in 
this chapter has been conducted by the group led by Prof. Dr. Fernando P. Cossío and by 
Dr. Abel De Cozar (Ikerbasque Research Fellow) at the University of the Basque Country 
(UPV/EHU). Because of this, details on computational methods are not provided in the 
experimental section and only the main results to confirm the mechanism of the reaction 
are presented in the section “results and discussion”.  
3.3. MATERIALS AND METHODS 
3.3.1. General Information 
Aniline (reagent plus grade 99%), sodium nitrite (ACS reagent, 97%), acetic acid 
(Reagentplus®, >99%), hydrazine hydrate solution (iodometric, 78-82%), and 
azidobenzene solution (0.5 M in tert-butyl methyl ether, >95%), methanesulfonamide 
(97%), p-toluenesulfonamide (Reagentplus®, >99%), sodium hydroxide, (ACS reagent, 
>97%), were purchased from Sigma-Aldrich and used without further purification. 
Hydrochloric acid (37%, extrapure, Ph. Eur.) and dichloromethane (synthesis grade) were 
purchased from Scharlau. Ultrapure water (Type I water, ISO 3696) was obtained from a 
Milli-Q® system (Merck Millipore). 
3.3.2. Radiochemistry: Synthesis of [13N]labelled phenylazide 
3.3.2.1. General  
All procedures were carried out under EU standards in terms of radioprotection and 
following internal procedures. Initial experiments to set up experimental conditions were 
performed manually in a lead-shielded hot cell (Manuela, Comecer) especially designed to 
conduct manual operations.  
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3.3.2.2.  Production of the primary labelling agent ([13N]NO2-) 
Nitrogen-13 was produced in an IBA Cyclone 18/9 cyclotron by irradiation of ultrapure 
water (1.8 mL) via the 16O(p,α)13N nuclear reaction. The irradiated solution, containing 
mainly [13N]NO3- and tiny amounts of [13N]NO2- and [13N]NH4+, was passed through a glass 
column filled with pre-treated cadmium (pellets, 15 g) to reduce [13N]NO3-  into [13N]NO2-. 
Pre-treatment was carried out by sequential elution with 1 M hydrochloric acid solution 
(25 mL), purified water (35 mL), copper (II) sulphate pentahydrate solution (20 g/L, 25 
mL), ammonium chloride solution (5 g/L, 25 mL) and purified water (25 mL). After the 
reduction step, the cadmium column was further rinsed with purified water (1 mL), the 
eluates were combined and used in subsequent steps.  
During initial experiments, a sample of this solution (20 µL) was routinely analyzed by 
HPLC to monitor the reduction of [13N]NO3- into [13N]NO2-. The analysis was carried out 
using an Agilent 1200 series HPLC equipped with a quaternary pump, a multiple 
wavelength detector and a radiometric detector (Gabi, Raytest). An HP Asahipak ODP-50 
(5 µm, 125x4 mm, Teknokroma, Spain) was used as stationary phase, and a solution 
containing additive for ionic chromatography (15 mL) in a mixture water/acetonitrile 
(86/14, V = 1L) basified to pH = 8.6 with 1M sodium hydroxide solution was used as the 
mobile phase at a flow rate of 1 mL/min. Simultaneous UV (λ = 254 nm) and isotopic 
detection (Gabi, Raytest) were used. Retention times for [13N]NH4+, [13N]NO2- and 
[13N]NO2-  were 1.1, 5.2 and 10.4 min, respectively.  
3.3.2.3. Preparation of 13N-labelled phenylazide via Dutt-Wormall reaction 
Preparation of 13N-labeled phenyl azides via Dutt-Wormall reaction [11] was carried out 
by adapting an already reported methodology [44],  based on the reaction of a diazonium 
salt with an aromatic sulfonamide. The whole synthetic procedure for the preparation of 
[13N]NO2- was carried out using the procedure followed in section 3.3.2.2 (see above). The 
solution containing [13N]NO2- was added drop-wise slowly to a second solution containing 
aniline (0.25 mmol) in ice-cold HCl (0.1mL of 37% HCl in 0.15mL water). The reaction for 
the formation of the diazonium salt was allowed to occur (4 minutes, T = 0°C). After 
extraction with dichloromethane to remove the excess of aniline, the aqueous layer of the 
reaction mixture was added drop wise to a vial pre-charged with an ice-cold solution of p-
toluene sulphonamide (0.25 mmol) in NaOH (1.60 mmol in 1 mL water) and the reaction 
for the formation of 13N-labelled azide was allowed to occur for (1 minute, T = 0°C). 
Finally, the 13N-labelled azide was extracted with dichloromethane. The solvent was 
evaporated and after quenching the reaction by dilution with aqueous ammonium formate 
(pH=3.9), radiochemical conversion was determined by radio-HPLC, using an Agilent 1200 
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Series HPLC system with a multiple wavelength UV detector (λ = 254 nm) and a 
radiometric detector (Gabi, Raytest). A RP-C18 column (Mediterranean Sea18, 4.6x250 
mm, 5 μm particle size) was used as the stationary phase and ammonium formate (pH = 
3.9) (A)/methanol (B) was used as the mobile phase. The following gradient was applied: 
t=0 min, 90%A/10%B; t=2 min, 90%A/10%B; t=4 min, 35%A/65%B; t=6 min, 
20%A/80%B; t=12 min, 20%A/80%B; t=15 min, 90%A/10%B. The presence of the 
desired labelled specie was confirmed by co-elution with reference standard (retention 
time = 9.6 min).  
3.3.2.4. Preparation of 13N-labelled phenylazide by reaction of hydrazoic acid with 
diazonium salt 
The preparation of 13N-labeled phenylazide using this reaction was conducted under two 
different scenarios, noted as A and B in Figure 3.2.  
For route B, the solution containing [13N]NO2- was added drop-wise to a second solution 
containing  aniline (23mg, 0.25 mmole) in HCl (0.1mL of 37% HCl in 0.15mL water). The 
reaction for the formation of the 13N-labelled diazonium salt was allowed to occur (1 
minute, RT). In a separate vial, a mixture of sodium nitrite solution (17mg in 0.1mL water, 
0.25 mmole), acetic acid (120 μL, 1.98 mmole) and hydrazine monohydrate solution (70 
μL, 1.41 mmole) was prepared and added drop-wise to the previous solution and the 
reaction for the formation of 13N-labeled azide was allowed to occur for 1 min at RT. The 
activity (A1) was measured in a dose calibrator (PETDOSE HC, Comecer), the vial was 
flushed with nitrogen gas (1 minute) and the activity was measured again (A2). The 
amount of [13N]N2 was calculated as A2-A1. The reaction crude was analyzed by HPLC using 
an Agilent 1200 Series HPLC system with a multiple wavelength UV detector (λ = 254 nm) 
and a radiometric detector (Gabi, Raytest). A RP-C18 column (Mediterranean Sea18, 
4.6x250 mm, 5 μm particle size) was used as stationary phase and ammonium formate 
(pH = 3.9) (A)/methanol (B) was used as the mobile phase. The following gradient was 
used: t=0 min, 90%A/10%B; t=2 min, 90%A/10%B; t=4 min, 35%A/65%B; t=6 min, 
20%A/80%B; t=12 min, 20%A/80%B; t=15 min, 90%A/10%B. The presence of the 
desired labelled specie was confirmed by co-elution with reference standard (retention 
time = 9.6 min). The amount of [13N]phenylazide was determined as the product (A2 x AU), 
where AU is the area under the peak for phenyl azide (radiometric detector, expressed as 
percentage with respect to all integrated peaks in the chromatogram). All radioactivity 
values were decay corrected to the same time point.  
For route A, the solution of [13N]NO2- prepared as mentioned above was added drop-wise 
to a solution containing hydrazine monohydrate solution (70 μL, 1.41 mmole) and acetic 
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acid (120 μL, 1.98 mmole), and the reaction was allowed to occur (1 minute, RT). In a 
separate vial, a solution of aniline (23mg, 0.25 mmole) in HCl (0.1mL of 37% HCl in 
0.15mL water) was reacted with sodium nitrite (17mg in 0.1mL water, 0.25 mmole) for 1 
minute at RT to form the non-radioactive diazonium salt. The first solution was added 
drop wise to the second solution (total duration 1 minute) and the reaction was allowed to 
occur (1 min, RT). Sample processing, identification of the labelled species and 
determination of the amount of [13N]N2 and [13N]phenyl azide was performed as in Route 
B (see above).  
3.3.2.5. Analysis of the radioactive gas [13N]N2 
The synthesis of 13N-labelled phenylazide was performed following the methodologies 
described above. However, before flushing the reaction vials with nitrogen gas, a sample of 
the gas from the sealed reaction vial was withdrawn with a gas-tight syringe and analyzed 
by radio-GC-MS. Analyses were performed on an Agilent 7820A network GC with an 
automatic loop injection system (loop volume = 250 µL) combined with an Agilent 5975c 
inert XL MSD with Triple axis detector. A  J&W Poraplot column (length 27.5m, internal 
diameter 0.32 mm) was used as stationary phase. The inlet conditions were 150 °C, 25 psi 
and a flow rate of 3.5 mL/min using a 1:10 split injector with helium (99.9999%) as the 
carrier gas. The oven temperature was set of 36°C. Total run time was 6 min (retention 
time = 1.45 min). Simultaneous detection using a radiometric detector (Gabi, raytest) and 
MS were used using a post-colum split. MS was operated in scan mode in the range 10-150 
Da.   
3.4. RESULTS AND DISCUSSION 
3.4.1. Synthesis of 13N-labelled azides by Dutt-Wormall reaction 
The synthetic process for the preparation of 13N-labeled aryl azides via Dutt-Wormall 
reaction is shown in Figure 3.3. 
 
Figure 3.3. Scheme of the reaction used for the preparation of 13N-labelled phenylazide via Dutt-
Wormall reaction.  
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In our first attempts, the reaction was carried out by reacting the 13N-labelled diazonium 
salt with methanesulfonamide under basic conditions. Different reaction times and 
reaction temperatures were assayed, but the formation of the desired labelled aryl azide 
could not be detected by radio-HPLC.  
In view of these results, we decided to use p-toluene sulfonamide under basic conditions, 
which has proven efficient in Dutt-Wormall reactions under non-radioactive conditions 
[11]. In a first set of experiments, the purification step based on extraction with 
dichloromethane was omitted; in other words, the solution containing the 13N-labelled 
diazonium salt was directly added to p-toluene sulfonamide in 1M NaOH. However, the 
formation of the desired 13N-labelled phenyl azide could not be detected. 
In order to check if the problem was the low concentration of labelled diazonium salt, 
carrier added tests (performed by addition of sodium nitrite to the [13N]NO2- solution used 
for the preparation of the labelled diazonium salt) were also carried out. Again, no positive 
results could be obtained. However, after incorporation of the intermediate purification 
step based on liquid-liquid extraction, the 13N-labelled phenylazide could be obtained in 
chromatographic yields close of 41±6%, suggesting that the large excess of starting, 
unreacted aniline may have a negative effect on the formation of the labelled azide. 
Interestingly, incorporation of sodium nitrite in 0.5:1 and 1:1 ratios with respect to aniline 
(carrier added conditions), improved the chromatographic yields up to 48±7% and 
53±8%, respectively (see table 3.3). Although the specific activity of the final labelled 
compound was not measured at this stage, the addition of the carrier always results in a 
dramatic decrease in the specific activity values. After final extraction with 
dichloromethane, pure azide could be obtained in the organic phase (Figure 3.4). As it can 
be seen in Figure 3.5, the aqueous phase contained mainly unreacted [13N]NO3- which was 
not reduced during the treatment in the cadmium column. The presence of an unidentified 
species at retention time = 4.6 minutes could be also detected.  
Table 3.3. Radiochemical conversion values for the preparation 13N-labelled azides via 
Dutt-Wormall reaction with different carrier concentrations. 
Entry Carrier amounta Chromatographic yield (%) 
1 1:1 53±8 
2 1:0.5 48±7 
3 0 41±6 
a Molar ratios with respect to aniline; results are expressed as mean±standard deviation, n=3.     
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Figure 3.4. Chromatographic profile (radioactive detector) after extraction with dichloromethane 
(organic phase). The presence of the pure labelled azide can be observed. 
Figure 3.5. Chromatographic profile (radioactive detector) after extraction with dichloromethane 
(aqueous phase). The presence of [
can be observed. 
3.4.2. Synthesis of 13N-labelled azides by reaction of diazonium salts with hidrazoic 
acid 
In view of the sub-optimal results obtained 
labelled azides was envisaged by reaction of diazonium salts with 
hydrazoic acid. In principle, at least three possible mechanisms can be envisaged for 
reaction. The first one consists of 
reactions of diazonium salts 
 
Figure 3.6. Potential mechanism of the reaction 
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13N]NO3- and one unidentified peak at retention time = 4.6 min 
via Dutt-Wormall reaction, the synthesis of the 
in situ
a SN2Ar process similar to that observed for solvolysis 
[45-48], as indicated in Figure 3.6.  
via SN2Ar.  
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A second plausible mechanism involves a thermal (3+2) cycloaddition to form a 1
pentazole cycloadduct [49]
reaction (Figure 3.7). 
Figure 3.7. Potential mechanism of the reaction 
Finally, an addition-elimination process 
according to Figure 3.8. 
Figure 3.8. Potential mechanism of the reaction 
Previous studies [43] suggest that this latter mechanism is quite plausible. The process 
involves the attack of the azide on the diazonium ion with formation of aryl pentazenes 
and/or pentazoles, which subsequently lose dinitrogen. Whether the reaction occurs 
through a concerted [3+2] mechanism or takes place step
intermediate products are questions that remain unresolved. Studies performed with 
and 15N-NMR spectroscopy suggest the formation of three isomeric aryl pentazenes
One of them would lead to the formation of the aryl azide directly, while the other two 
would require the formation of intermediate ring structures to finally yield the aryl azide.
It is worth mentioning that when transitioning to radioactive conditions the reaction 
mechanism may have an impact on radiochemical yield. If the reaction proceeds 
mechanism shown in Figure 3.6, 
anion should be completely transferred to the corresponding aryl azide; however, if the 
radiolabelled diazonium salt is reacted with non
would never be obtained. Similar reasoning can be applied to mechanisms shown in 
Figures 3.7 and 3.8; hence the position of the label is paramount to prevent formation of 
[13N]N2 with the consequent decrease in labelling efficiency. With the aim of optimizing 
radiochemical yields, we envisaged a unique opportunity to further explore the 
mechanism of this reaction. 
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Both synthetic strategies (noted as A and B in Figure 3.2) led to the formation of 13N-
labeled phenyl azide (see Figure 3.9). However, the amount of radioactive gas generated 
during the reaction, determined as the difference between A1 and A2, and referred to the 
total amount of 13N-labelled azide (the latter calculated as the product A2 x AUC, where AUC 
is the area under the peak for phenyl azide as measured in the radiometric detector and 
expressed as percentage with respect to all integrated peaks in the chromatogram) was 
100.3±1.7% and 4.0±1.1% for strategies A and B, respectively. Analysis of the flushed gas 
by radio-GC-MS showed the presence of a single radioactive peak, which was identified as 
[13N]N2 while the amount of labelled azide obtained in route B was twice the amount 
obtained in A. These results confirm that approximately half of the radioactivity is lost as 
[13N]N2 when route A is followed, while the information of the radiolabel is almost 
quantitatively transferred to the azide under route B (Figure 3.2). 
 
Figure 3.9: HPLC Chromatographic profile of the reaction mixture. The labelled azide appears at 
t=9.6 min.  
The experimental data completely discard the reaction mechanism based on SN2Ar (Figure 
3.6) and cleavage of the C–heteroatom bond, which would lead to complete radioactivity 
loss (as [13N]N2) when route B is followed. On the other hand, they strongly suggest that 
the formation of the intermediate ring (Figure 3.7) is not taking place; in such a case, 
[13N]N2 would be detected in significant amount (c.a. 100% with respect to the final 
amount of labelled aryl azide) when route B was used.  
It is worth mentioning that the maximum amount of labelled azide was obtained when 
Route B was followed (Figure 3.2), with the radiolabel almost quantitatively transferred to 
the azide. Therefore, this route was considered as the most appropriate to achieve optimal 
results.  
 
CHAPTER 
 
3.4.3. Computational  Results
In view of the experimental 
on the parent PhN2+(1)+N3-
most plausible reaction mechanism and get a better understanding of the 
data. A M06-2X [51, 52] (PCM)  
aqueous solution revealed the presence of a local minimum associated with a weak 
complex formed denoted as 
Figure 3.10. (A) Electrostaic potential and chief geometric features of complex RC associated with 
the interaction between azide anion and diazonium cation 
Å and deg., respectively. Numbers in square brackets are the corresponding bond indices. (B) 
Selected Kohn-Sham molecular orbitals of RC. Descriptors 
the local Fukui indices. 
This stationary point on the potential energy surface (PES) consists of a charge transfer 
complex, in which both reactants are in close contact. The new N
2.4-2.5 Å (Figure 3.10 A), the respective Wiberg bond indices 
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results described above, we performed DFT 
→PhN3(2)+N2 reaction in order to obtain evidences about the 
[53, 54] /def2-TZVPP [55] study of the reactants in 
RC in Figure 3.10.  
1. Bond distances and angles are given in 
f+ on the nitrogen atoms correspond to 
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weak bonding pattern stems form a two
molecular orbitals (MO’s) of the azide anion an
3.10B). The occupied MO’s π
interaction (not shown), thus resulting in a very weak bonding pattern between both 
reactants at RC. Actually, this stationary point is not stabilized with respect to t
reactants at 298 K (Figure 3.11)
From these reactants we characterized saddle 
activation energy of ca. 27 kcal/mol. The geometric featu
quite similar to those obtained for solvolysis reactions of aromatic diazonium salts 
our case, however, there is an additional interaction between the diazonium and azide 
moieties (Figure 3.10 A). This remarkable barrier and our experimental results permit to 
discard the SN2Ar mechanism for this particular
Figure 3.11. M06-2X/def2-TZVPP reaction profiles associated with the reaction between 
diazonium cation 1 and azide anion to yield phenyl azide 
reactants, intermediates and product
the arrows indicate the respective activation energies, in kcal/mol. Numbers in parentheses indicate 
the respective Gibbs energies, computed at 298 K, in kcal/mol. The lowest energy reaction pa
highlighted in red and blue. 
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The frontier MO’s of the reactants at RC are also indicated in Figure 3.10 B and correspond 
to in-plane σ-MO’s e2g” and π*”. These computational data are compatible with a high 
electrophilicity associated with the terminal nitrogen of the diazonium moiety of 1, with a 
local electrophilic Fukui index [57-59] f+ of 0.32 a.u. (Figure 3.10 B). The interaction 
between the terminal nitrogen atoms of both reactants according to the mechanism 
reported in Figure 3.8 lead to saddle points s-cis- and s-trans-TS1 (Figure 3.11). The 
former transition structure was calculated to be ca. 7 kcal/mol less energetic than the 
latter. The chief geometric features of s-cis-TS1 closely resemble those expected for an 
asynchronous transition structure associated with a (3+2) cycloaddition  [60, 61]. 
However; all our attempts to connect directly s-cis-TS1 with 2-phenyl-2H-pentazole 
INTper were unfruitful. Instead, this saddle point led to zwitterionic intermediate s-cis-
INT1, from which we located transition structure TS1per. This latter saddle point led to 2-
phenyl-2H-pentazole INTper (Figure 3.11), associated with this hypothetical (3+2) 
cycloaddition. From this local minimum we found saddle point TS2per leading to phenyl 
azide 2. Although this latter transition structure associated with a retro-(3+2) 
cycloaddition is compatible with the reaction scheme gathered in Figure 3.7, it is 
important to note that INTper does not stem from RC but from s-cis-INT1, which 
constitutes the key intermediate of the less energetic reaction profiles. In addition, our 
calculations indicate that formation of INTper occurs with an activation barrier that is ca. 
2 kcal/mol higher than that associated with formation of phenyl azide 2. 
Intrinsic Reaction coordinate [62] (IRC) scans from both s-cis- and s-trans-TS1 led to the 
corresponding zwitterionic intermediates s-cis- and s-trans-INT (see Figures 3.12 and 
3.13). The relative stabilities of these polar intermediates were found to be the opposite 
ones with respect to the corresponding transition structures. Therefore, the preferred 
route to yield azidobenzene 2 and dinitrogen occurs via s-cis-TS2 in which the cleavage of 
the PhN3(-)-N2(+) delocalized bond is produced (Figure 3.11). This low barrier is 
associated with the formation of dinitrogen and azidobenzene 2, two neutral stabilized 
species. 
In order to confirm the preference for the mechanism outlined in Figure 3.8 we carried out 
Car-Parrinello [63] Molecular Dynamics (CPMD) [by using CPMD code 
(http://www.cpmd.org)] within the DFT framework, using the BLYP gradient-corrected 
functional [64, 65] and ultrasoft Vanderbilt pseudopotentials [66]. These simulations were 
carried out at different temperatures with a 1 fs time step for integration of equations of 
motion. Our CPMD results for the entire PhN2+(1)+N3- PhN3(2)+N2 reaction confirmed 
that the reactants form s-cis-INT zwitterion in less than 100 fs at 100 K (Figure 3.14). This 
→
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intermediate is stable at this temperature within a time span of at least 1.2 ns. When the 
system was heated at ca. 300 K, the 
reaction products [67],  thus confirming the stepwise nature of the reaction 
intermediates of type INT. These results are in agreement
and provide a rationale for the loss of radioactivity observed when radiolabelled azide 
anion was used following method A (Figure 3.2).
Figure 3.12. Chief geometric features (M06
gathered in Figure 3.11. Bond distances and angles are given in Å and deg., respectively.
Figure 3.13. M06-2X/def2-TXVPP relative energies (in kcal/mol, numbers in parentheses) and 
relative Gibbs energies (at 298
intermediates s-cis- and s-trans
transition structure TSrot that connects both conformers are also indicated.  Bond distances and 
angles are given in Å and deg., respectively. Dihedral angle 
bond. 
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Figure 3.14. Car-Parrinello Molecular Dynamics (CPMD) plots of the reaction
cation 1 and azide anion to yield phenyl azide 2 and dinitrogen.
 
Kinetic simulations carried out using reaction paths highlighted in red and blue in Figure 
3.11 indicate that ca. 99% of 
product is formed via INTper
[13N]N2 obtained in our experimental studies following synthetic strategy shown in Figure 
3.2, method A. 
3.5.  SUMMARY AND CONCLUSIONS
In conclusion, we have demonstrated using experimental and computational data that the 
formation of aryl azides from the corresponding diazonium salts occurs 
mechanism via acyclic zwitterionic intermediates. The use of the short
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emitter nitrogen-13 for the elucidation of reaction mechanisms is unprecedented. 
Additionally, we have demonstrated that the production of 13N-labelled azides can be 
approached by using the methodology reported here. This provides unprecedented 
opportunities to tackle the preparation of more complex molecules, with the labelled 
heteroatom placed in the heterocycle, as demonstrated in the two following chapters.  
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4. SYNTHESIS OF 13N-LABELLED TRIAZOLES  
4.1. INTRODUCTION 
Triazoles are heterocyclic compounds with molecular formula C2H3N3, having a five-
membered ring with two carbon atoms and three nitrogen atoms. There are two sets of 
isomers that differ in the relative positions of the three nitrogen atoms: 1,2,3- and 1,2,4-
triazoles. In 1,2,3- triazoles, the three adjacent nitrogen atoms occupy adjacent positions, 
and can exist in two different tautomeric forms, depending on the nitrogen atom with a 
hydrogen bonded to it (Figure 4.1).  
 
Figure 4.1. Chemical structure of 1,2,3- and 1,2,4-triazole in the two different tautomeric forms. 
The 1,2,3-triazole core is stable against acidic and basic hydrolysis as well as against 
oxidative and reductive conditions [1],  it has a high dipole moment [2] and participates 
actively in hydrogen bond formation as well as in dipole–dipole interactions [3]. These 
features make the variously substituted triazole moiety structurally similar to the amide 
(peptide) bond, but with more marked hydrogen-bonding donor and acceptor properties. 
Beyond mimicking the amide moiety, 1,2,3-triazoles can act as bioisosteres of trans-
olefinic moieties [4] and have been used to replace the trans-olefinic moiety of resveratrol 
(anti-cancer, anti-inflammatory drug) [4] and diethylstilbestrol (non-steroidal estrogen), 
the latter leading to the synthesis of analogue molecules with estrogenic activity [5].  
The above mentioned unique features turn 1,2,3-triazoles into convenient building blocks 
for the preparation of active drugs. One of the best-known examples of triazole-containing 
drugs is tazobactam (Figure 4.2, left) a commercially available β-lactamase inhibitor. Still 
in the antibiotics field, triazoles have been also used to improve pharmacokinetic 
properties of desired drugs. For example, cephalosporins with good oral availability were 
obtained by linking the triazole moiety to the cephalosporin (Figure 4.2, right). 
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Figure 4.2. Example of β-lactamase inhibitors incorporating the 1,2,3-triazole moiety; left: 
tazobactam; right: example of a cephalosporin incorporating the triazole ring.    
Beyond the antibiotics area, 1,2,3-triazoles have been assayed as anticancer agents, 
antimycotic agents, anthelmintic agents, potassium channel activators, protein kinasse 
inhibitors, histone deacetylase (HDAC) inhibitors, ligands for specific receptors and 
antiviral agents, among others. Interestingly, polysubstituted triazoles have also shown 
promising properties to bind β-Amyloid aggregates (Figure 4.3). An excellent review 
covering the multiple biological applications of triazoles has been recently published [6]. 
In view of the multiple applications of triazole rings in the preparation of drugs, it is clear 
that the development of a method for the preparation of triazoles radiolabelled with 
positron emitters might become a powerful tool for the fast, in vivo and non-invasive 
evaluation of triazole-containing, newly developed drug candidates.   
 
                
Figure 4.3. Example of substituted 1,2,3-triazoles with the capacity to bind β-Amyloid aggregates. 
Left: 4-[1-(4-iodophenyl)-1H-1,2,3-triazol-4-yl]-N-methylaniline; right: 4-[1-(4-iodophenyl)-1H-1, 
2, 3-triazol-4-yl]-N,N-dimethylaniline. 
Because positron emitters usually have a short half-life, the utilization of fast and efficient 
synthetic strategies is paramount in order to obtain acceptable radiochemical yields and a 
sufficient amount of radioactivity suitable for the eventual use in pre-clinical or clinical 
imaging studies.   
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To date, several different strategies for the preparation of 1,2,3-triazoles have been 
developed. One of the most popular and widely used synthetic methodologies is the 
cycloaddition of azides and terminal alkynes (Figure 4.4) or aldehydes (Figure 4.5).  
 
Figure 4.4. Preparation of triazoles by the (3+2) cycloaddition of azides with alkynes. 
 
 
Figure 4.5. Preparation of triazoles by the organocatalytic (3+2) cycloaddition of azides with 
aldehydes. 
The above mentioned reactions for the formation of triazoles fall within the general 
category of 1,3-dipolar cycloadditions, which involve a 1,3-dipole and a dipolarophile to 
form a five-membered ring. The first 1,3-dipolar cycloadditions were described at the end 
of the 19th century and beginning of the 20th century, following the discovery of 1,3-
dipoles. In the 1960s, Rolf Huisgen developed the mechanistic investigation and described 
synthetic  applications of the reaction [7]. Because of this, the reaction is nowadays 
referred to as the Huisgen cycloaddition, term that is most commonly used for those 
reactions resulting in the formation of 1,2,3-triazoles involving the condensation of azides 
and alkynes.  
The Huisgen reaction is widely applied because it represents an excellent alternative for 
the preparation of 5-membered heterocycles. However, this reaction suffers from several 
drawbacks, which include the formation of a mixture of 1,4- and 1,5-regioisomers [1], 
which might be difficult to isolate; additionally, the reaction requires long reaction times 
and heating for completion under non catalytic conditions. In 2002, two research groups 
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reported independently the copper(I) catalyzed alkyne-azide cycloaddition (CuAAC) 
which proceeds as much as 107 times more rapidly than the non-catalyzed reaction [8-10]. 
More importantly, the reaction could be conducted at room temperature or under 
moderate heating, yielding only the formation of the 1,4-regioisomer.  
Despite the advantages of CuAAC, the formation of two regioisomers has been observed in 
some occasions, with relative ratios close to 1:1. Because of this, many research groups 
have actively worked on the development of orthogonal cycloaddition reactions yielding 
exclusively 1,5-disubstituted regioisomer. In 2005, pentamethylcyclopentadienyl 
ruthenium(II) complexes (Cp*Ru), such as Cp*RuCl(PPh3)2, were reported to act as 
efficient catalysts for the cycloaddition reaction involving alkynes and azides. Unlike all of 
the previously reported catalysts, Cp*Ru complexes yielded only 1,5-substituted 1,2,3-
triazoles [11]. Additionally, condensations using internal alkynes could be carried out with 
high efficiency. These reactions could not be achieved when copper catalysts were used. 
More recent works have shown that Cp*RuCl(PPh3)2 or Cp*RuCl(COD) enable the 
condensation of primary and secondary azides with a broad range of terminal alkynes 
containing a range of functionalities, selectively producing 1,5-disubstituted 1,2,3-
triazoles [12]. In 2013, the development of  a mild, zinc-mediated method for the 
regioselective formation of 1,5-substituted 1,2,3-triazoles was reported [13]. 
 
4.2. AIM AND OBJECTIVES 
The copper(I) alkyne-azide cycloaddition reaction has been widely used for the 
preparation of positron-emitter labelled molecules [14], including proteins [15, 16], 
peptides [17-21]  and  small molecules[22]. However, it has never been applied to the 
preparation of 13N-labelled radiotracers.  
In our aim to develop novel strategies for the preparation of 13N-labelled radiotracers, and 
taking advantage of the methodology for the preparation of labelled azides developed in 
chapter 3 of this PhD thesis, we envisaged the possibility to use the Huisgen cycloaddition 
to approach the unprecedented preparation of 13N-labelled heterocycles incorporating the 
13N atom in the heterocycle. To achieve this goal, the following specific objectives were 
established:  
1. To develop a synthetic strategy for the preparation of 13N-labelled polysubstituted 
triazoles 4.1-4.6 (Figure 4.6) by the reaction of 13N-labelled aromatic azides with 
alkynes via (3+2) Huisgen cycloaddition. 
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2. To develop a synthetic strategy for the preparation of 13N-labelled polysubstituted 
triazole 4.1 (Figure 4.6) by the reaction of 13N-labelled aromatic azides with aldehydes 
via (3+2) Huisgen cycloaddition. 
3. To implement an automated procedure for the preparation of 13N-labelled triazoles in 
a robust, safe and efficient fashion. 
 
Figure 4.6. 13N-labelled triazoles prepared in this thesis. 
4.3. MATERIALS AND METHODS 
4.3.1. General Information 
Aniline (reagent plus grade 99%), 4-iodoaniline (98%), sodium nitrite (ACS reagent, 97%), 
acetic acid (Reagentplus®, >99%), hydrazine hydrate solution (iodometric, 78-82%), 
cyclohexylamine (Reagentplus®, >99%), paraformaldehyde (reagent plus grade 
crystalline), glyoxal solution (40 wt. % in H2O), sodium carbonate (ACS reagent, 
anhydrous), magnesium sulphate (ACS reagent, anhydrous, >99.5%), sodium sulphate 
(ACS reagent, anhydrous, >99%), tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(97%), sodium tert-butoxide (97%), Celite® S (filter aid, dried, untreated), copper (II) 
sulphate pentahydrate (ACS reagent, >98%), copper (I) oxide (>99.99%),  copper (I) 
iodide, purum, (>99.5%), N,N-Diisopropylethylamine (Reagentplus®, >99%), sodium 
ascorbate (Pharmaceutical secondary standard), 1,8-diazabicycloundec-7-ene (DBU, 
98%), methanesulfonamide (97%), p-toluenesulfonamide (Reagentplus®, >99%), Sodium 
hydroxide, (ACS reagent, >97%), azidobenzene solution (0.5 M in tert-butyl methyl ether, 
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>95%), 1-azido-4-iodobenzene solution (0.5 M in tert-butyl methyl ether, >95%), 4-
ethynyl-N,N-dimethylaniline (97%), phenyl acetylene (98%), ethyl propiolate (99%), 1-
hexyne (97%), 1-octyne (97%), 4-ethynyltoluene (97%), phenylacetaldehyde (>90%), 
hydrochloric acid (37%, extrapure, Ph. Eur.), 1-hexanal (98%), 1-octanal (99%), 
tetrahydrofuran (absolute over molecular sieve, >99.5%), and dimethyl sulfoxide 
(anhydrous, >99.9%) were purchased from Sigma-Aldrich and used without further 
purification. Hexane (synthesis grade), ethyl acetate (synthesis grade), dichloromethane 
(synthesis grade), acetonitrile (HPLC grade) and diethyl ether (extra pure) were 
purchased from Scharlab (Sentmenat, Barcelona, Spain). Ultrapure water (Type I water, 
ISO 3696) was obtained from a Milli-Q® purification system (Merck Millipore). 
4.3.2. Synthesis of reference compounds 4.1-4.6 
The synthesis of the reference compounds 4.1-4.6 was approached via (3+2) azide-alkyne 
cycloaddition following a previously published method [23]. In brief, the corresponding 
alkyne (2.54 mmol), CuSO4.5H2O (catalyst, 0.169 mmol) and an aqueous solution of 
sodium ascorbate (0.845 mmol in 1 mL) were added to a stirred solution of the 
corresponding azide (1.69 mmol). The vial was capped and submitted to microwave 
heating (80°C, 125W max, 10 min) using a Biotage® Initiator 2.0, 400 W and the reaction 
was monitored by TLC. Ultrapure water (25 mL) was added, the precipitate was filtered 
and washed with water (2 x 10 mL). Extraction with petroleum ether (40-60, 2 x 10 mL) 
was followed by evaporation using a rota-evaporator and the pure triazoles 4.1-4.6 were 
obtained.   
The characterization of the pure compounds was carried out using Nuclear Magnetic 
Resonance (1H- and 13C-NMR) and Mass Spectrometry (MS), and characterization data was 
compared to literature [23-25]. 
4.3.3. Radiochemistry: Synthesis of compounds [13N]4.1-[13N]4.6 
4.3.3.1. General  
All procedures were carried out under EU standards in terms of radioprotection and 
following internal procedures. Personnel protection measures and dose-exposure 
monitorization were applied over the entire duration of the experimental work. Initial 
experiments to set up experimental conditions were performed manually in a lead-
shielded hot cell (Manuela, Comecer) especially designed to conduct manual operations. 
After optimization of the experimental conditions, the whole synthetic procedure for the 
preparation of the selected labelled compound was carried out using an automatic 
synthesis module (see below for experimental details). 
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4.3.3.2. Production of the primary labelling agent 
The whole synthetic procedure for the preparation of [13N]NO2- was carried out using 
same procedure followed in the chapter 3 (see above). 
4.3.3.3. Production of 13N-labelled azide 
The whole synthetic procedure for the preparation of 13N-labelled phenylazide and 13N-
labelled 1-azido-4-iodobenzene were carried out using same procedure followed in route 
B, chapter 3. In brief, Nitrogen-13 was produced in an IBA Cyclone 18/9 cyclotron by 
irradiation of ultrapure water. The irradiated solution was passed through a glass column 
filled with pre-treated cadmium to reduce [13N]NO3- into [13N]NO2-. After the reduction 
step, the cadmium column was further rinsed with purified water (1 mL), the eluates were 
combined and used in subsequent steps. The solution containing [13N]NO2- was added to a 
second solution containing  the corresponding aniline (0.25 mmol) in HCl (0.1mL of 37% 
HCl in 0.15mL water). In the case of [13N]4.6, MeOH (0.5 mL) was added to favour 
solubilisation of 4-iodoaniline. The reaction for the formation of the diazonium salt was 
allowed to occur for 1 minute at room temperature (RT). In a separate vial, a mixture of 
sodium nitrite solution (0.25 mmol in 0.1mL water), acetic acid (2.0 mmol) and hydrazine 
monohydrate solution (1.5 mmol) was prepared and added to the previous solution, and 
the reaction for the formation of 13N-labelled azide was allowed to occur for 1 min. Finally, 
the 13N-labelled azide was extracted with dichloromethane (1 mL) and the organic fraction 
was evaporated to dryness under a stream of nitrogen. 
4.3.3.4. Production of 13N-labelled triazoles ([13N]4.1-[13N]4.6) 
Via (3+2) cycloaddition of azide and alkyne  
Previously prepared [(Icy)2Cu]PF6 catalyst (2 mg in 0.2 mL of acetonitrile) and the 
corresponding alkyne (0.14 mmol) were added to the 13N-labelled azide and the reaction 
was allowed to occur for 10 minutes at different temperatures (25°C or 50°C). After 
quenching the reaction by dilution with aqueous ammonium formate (pH=3.9), 
radiochemical conversion was determined by radio-HPLC, using an Agilent 1200 Series 
HPLC system with a multiple wavelength UV detector (λ = 254 nm) and a radiometric 
detector (Gabi, Raytest). A RP-C18 column (Mediterranean Sea18, 4.6x250 mm, 5 μm 
particle size) was used as the stationary phase and ammonium formate (pH = 3.9) 
(A)/methanol (B) was used as the mobile phase (compounds [13N]4.1, [13N]4.3, [13N]4.4, 
and [13N]4.5). The following gradient was applied: t=0 min, 90%A/10%B; t=2 min, 
90%A/10%B; t=4 min, 35%A/65%B; t=6 min, 20%A/80%B; t=12 min, 20%A/80%B; t=15 
min, 90%A/10%B. For compounds [13N]4.2 and [13N]4.6, ammonium formate (pH = 
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3.9)/acetonitrile (40/60, V/V) and 0.1% TFA in water/actonitrile (40/60 V/V) were used 
in isocratic mode, respectively. The presence of the desired labelled species was confirmed 
by co-elution with reference standards. Retention times for [13N]4.1-4.6 were 8.7, 12.5, 
8.7, 10.0, 7.8 and 3.4 min, respectively.  
Via (3+2) cycloaddition of azide and aldehyde  
The 13N-labelled phenylazide was prepared following the above mentioned procedure. The 
catalyst (DBU, 0.021 mmol in 0.2 mL of DMSO) and phenylacetaldehyde (0.136 mmol) 
were then added and the reaction was allowed to occur for 10 minutes at different 
temperatures (25°C or 60°C). The reaction was quenched by addition of aqueous 
ammonium formate (pH=3.9), and radiochemical conversion was determined by radio-
HPLC using the same methodology as above.   
Incorporation of SPE-based intermediate purification step 
The procedure for the preparation of 13N-labelled azide was the same as described above, 
but the reaction mixture containing the 13N-labelled azide was purified by solid phase 
extraction. This procedure was applied to compounds 4.1 and 4.6. With that aim, 7 mL of 
0.5M sodium acetate solution ([13N]4.1) or ultrapure water ([13N]4.6) was added to the 
reaction mixture and the resulting solution was passed through a C-18 Cartridge (Sep-Pak 
C18 Plus, Waters). The cartridge was rinsed with ultrapure water (2mL) and subsequently 
flushed with helium gas for 1 minute. Finally the C-18 Cartridge was eluted with 
acetonitrile (1mL), the liquid was collected in a vial containing the corresponding alkyne 
and the catalyst and the resulting mixture was allowed to react for 10 min at 50°C. The 
reaction mixture was finally diluted with mobile phase and analyzed by HPLC using the 
conditions mentioned above. 
4.3.3.5. Automatic synthesis of [13N]4.6 
Automatisation of the entire synthetic procedure was applied to the preparation of 
compound [13N]4.6, using a TracerlabTM FXFE synthesis module (GE Healthcare) with 
modifications on its original configuration (See Figure 4.7). Vials 1-9, represented with 
green numbers in the Figure, were pre-loaded with the following reagents: 
1. Vial 1: Empty 
2. Vial 2: 1.0 mL of purified water 
3. Vial 3: Mixture of 4-iodoaniline (0.25 mmol) + HCl 37% (0.1 mL) + purified water 
(0.15 mL) + MeOH (0.5 mL) 
4. Vial 4: Sodium nitrite aqueous solution (0.25 mmol/1mL), acetic acid (2.0 mmol) 
and hydrazine monohydrate aqueous solution (1.5 mmol). 
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5. Vial 5: Purified water (7 mL) 
6. Vial 6: Purified water (2 mL) 
7. Vial 7: Acetonitrile (1 mL) 
8. Vial 8: 4-ethynyl-N,N-dimethylaniline (0.14 mmol), [(Icy)2Cu]PF6 (10 mg). 
9. Vial 9: Empty 
10. Final Vial: Empty 
 
 
Figure 4.7. Schematic representation of the automated synthesis module used for the production of 
[13N]4.6. Vials 1-9 are indicated with green numbers. Normally open positions for 3-way valves are 
indicated with a dot. All 2-way valves are normally closed. 
A C-18 (Sep-Pak® C18 Plus, Waters) and a filtering membrane were installed in the 
indicated locations (see Figure 4.7). Normally open positions for 3-way valves are 
indicated with a dot. All 2-way valves are normally closed. If not indicated otherwise, 
valves are returned to starting position after each individual step. Reaction time, reaction 
temperature and the amount of catalyst were varied in order to find optimal experimental 
conditions. 
The procedure followed, step by step, is summarized in Table 4.1. In brief, Nitrogen-13 
was produced in an IBA Cyclone 18/9 cyclotron via the 16O(p,α)13N nuclear reaction. The 
target was filled with ultrapure water (1.8 mL) and irradiated with 18 Mev protons. The 
1 2 3 4 5 6 7
8
9
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irradiated solution containing [13N]NO3-, [13N]NO2- and [13N]NH4+ was transferred to the 
synthesis box and collected in vial 1, which had a venting needle (step 1, Table 4.1).  
Table 4.1. Step-by-step procedure followed for the preparation of [13N]4.6 using the TracerlabTM 
FXFE synthesis module; NA: Not applicable. 
Step Operations Process 
1 NA The activity of the target is transferred to vial 1.  
2 V5 and V15 open 
The solution containing [13N]NH4+, [13N]NO2- and 
[13N]NO3- is transferred to the cadmium column. 
3 V5, V10, V15 and V19 open 
The solution containing [13N]NO2- and residual 
amounts of [13N]NH4+ and [13N]NO3- is transferred to 
the first reactor. 
4 
V8 up, V10, V15 and V19 
open 
The cadmium column is rinsed with ultrapure water 
and the eluate is collected in the first reactor 
5  V1, V15 and V19 open 
The solution containing 4-iodoaniline, HCl 37%, 
purified water and MeOH is added to the reactor and 
the reaction for the formation of the labeled 
diazonium salt is allowed to occur. 
6 V2, V15 and V19 open 
The solution containing sodium nitrite, acetic acid and 
hydrazine monohydrate is added to the reactor and 
the reaction for the formation of the labeled azide is 
allowed to occur. 
7 V3 and V19 open The reaction crude is diluted with purified water 
8 
V9 and V18 open, reactor 
needle down 
The reaction crude is flushed through the C-18 
cartridge and the eluate is collected in the waste 
9 V4 and V15 open, V6 right 
The C-18 cartridge is flushed with purified water and 
the eluate is collected in the waste. The cartridge is 
further dried with helium gas. 
10 
V14 and V15 open, V6 and 
V13 right, V12 down 
The C-18 cartridge is flushed with acetonitrile and the 
eluate is collected in vial 8. The reaction for the 
formation of labeled triazole is allowed to occur under 
heating.   
11 
V14 and V15 open, V6 and 
V13 right, V7 left.  
The reaction crude is transferred to vial 9 through the 
filter membrane.  
12 V16 left, V17 right 
The reaction crude is loaded in the loop and injected 
into the HPLC system. The radioactive signal is 
monitored and the desired peak is collected by 
switching V11. 
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After completion of the transfer, the venting needle was removed from vial 1 and the 
solution was transferred to a glass column filled with cadmium to reduce [13N]NO3- into 
[13N]NO2- in 1 minute (step 2, Table 4.1). The solution was afterwards pushed to a reactor 
(step 3, Table 4.1), and then rinsed with 1.0 mL of ultrapure water, previously loaded in 
vial 2 (step 4, Table 4.1). The acidic solution loaded in vial 3, containing 4-iodoaniline, HCl 
37%, purified water and MeOH, was added to the reactor and the reaction for the 
formation of the labelled diazonium salt was allowed to occur for 30 seconds (step 5, 
Table 4.1). A solution containing a mixture of aqueous sodium nitrite solution, acetic acid 
and hydrazine monohydrate (Vial 4) was then added to the reactor and the reaction for 
the formation of labelled azide was allowed to occur for 90 seconds (step 6, Table 4.1). 
After completion of the reaction, ultrapure water (7 mL, Vial 5) was added to the reactor 
(step 7, Table 4.1) and the resulting solution was passed through the C-18 Cartridge to 
trap the labelled azide (step 8, Table 4.1). The cartridge was further rinsed with ultrapure 
water (2 mL, vial 6) and subsequently dried with helium gas for 1 minute (step 9, Table 
4.1). The cartridge was rinsed with acetonitrile (1 mL, Vial 7) and the eluate was collected 
in vial 8, pre-loaded with 4-ethynyl-N,N-dimethyl aniline and [(Icy)2Cu]PF6, and the 
resulting mixture was allowed to react for 5 min at T=110°C (step 10, Table 4.1).  
Purification was achieved by semi-preparative HPLC. The reaction mixture was cooled in 
an ice cold bath, filtered and transferred to vial 9 (step 11, Table 4.1). The reaction 
mixture was finally injected in the HPLC loop (step 12, Table 4.1). A RP-C18 column 
(Mediterranean Sea18, 10x250 mm, 5 μm particle size) was used as the stationary phase 
and 0.1% TFA in water/actonitrile (50/50 V/V) was used as the mobile phase with a flow 
rate of 7ml/min. The desired fraction (retention time = 6.5 min) was collected in the final 
vial.  
Chemical and radiochemical purities of the radiotracer were determined using radio-
HPLC, using an Agilent 1200 Series HPLC system with a multiple wavelength UV detector 
(λ = 254 nm) and a radiometric detector (Gabi, Raytest). A RP-C18 column (Mediterranean 
Sea18, 4.6x250 mm, 5 μm particle size) was used as stationary phase and 0.1% TFA in 
water/actonitrile (40/60 V/V) as the mobile phase. The presence of the desired labelled 
specie was confirmed by co-elution with reference standard (retention time = 3.4 min). 
4.4. RESULTS AND DISCUSSION 
4.4.1. Preparation of the reference compounds 
Radiochemical reactions carried out under non-carrier added conditions lead to the 
formation of small amounts of the desired compound in terms of mass. Hence, classical 
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analytical tools such as NMR cannot be utilised to determine the structure of the labelled 
compounds. Instead, co-elution of the labelled compounds with reference standard 
compound using HPLC is widely applied to unambiguously identify the labelled species. 
Hence, the first step in this work was the preparation of non-radioactive compounds with 
the same structure as the target compounds. Methodologies previously described in the 
literature were used. Characterization data obtained by 1H- and 13C-NMR as well as mass 
spectrometry were compared to literature data (see Table 4.2).  
Table 4.2. Characterizastion data for compounds 4.1-4.6. 
 Name / Structure Characterization data 
4.1 
1, 4-Diphenyl-1H-1, 2, 3-triazole 
 
White solid.  
1H NMR (500 MHz, CDCl3) δ: 8.23 (s, 1H), 7.94 
(d, J=7.2 Hz, 2H), 7.82 (d, J=7.6 Hz, 2H), 7.58 (t, 
J=8 Hz, 2H), 7.48-7.51 (m, 3H), 7.40 (t, J=7.2 
Hz, 1H). 
13C NMR (125.7 MHz, CDCl3) δ: 132.5, 130.3, 
129.7, 128.9, 128.7, 128.4, 128.0, 127.8, 125.7, 
120.5.  
HRMS Calculated for C14H12N3 (MH+): 222.257; 
found: 222.168. 
4.2 
4-Phenyl-1-p-tolyl-1H-1, 2, 3-triazole 
  
White solid.  
1H NMR (500 MHz, CDCl3) δ: 8.18 (s, 1H), 9.92 
(d, J=7.2 Hz, 2H), 7.71 (d, J= 7.6 Hz, 2H), 7.49 (t, 
J=7.6 Hz, 2H), 7.36-7.41 (m, 3H), 2.47 (s, 3H).  
13C NMR (125.7 MHz, CDCl3) δ:138.8, 134.2, 
130.3, 130.2, 128.9, 128.3, 125.8, 120.4, 117.6, 
21.1. 
HRMS Calculated for C15H14N3 (MH+): 236.283; 
found: 236.186. 
4.3 
1-Phenyl-4-butyl-1, 2, 3-triazole 
 
White solid. 
1H NMR (500 MHz, CDCl3) δ: 7.76 (s, 1H), 7.65 
(d, J= 8Hz, 2H), 7.42 (t, J=8 Hz, 2H), 7.33 (t, 
J=7.2 Hz, 1H), 2.74 (t, J=7.2 Hz, 2H), 1.65- 1.68 
(m, 2H), 1.34-1.37 (m, 2H), 0.90 (t, J=6.4, 3 H);  
13C NMR (125.7 MHz, CDCl3) δ: 136.5, 130.2, 
130.0, 129.4, 123.2, 128.8, 30.8, 24.2, 22.2, 
13.7;  
HRMS Calculated for C12H16N3 (MH+): 202.267; 
found: 202.123. 
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 Name / Structure Characterization data 
4.4 
1-Phenyl-4-hexyl-1, 2, 3-triazole 
 
White solid;  
1H NMR (500 MHz, CDCl3) δ: 7.77 (s, 1H), 7.34 
(d, J=7.6 Hz, 2H), 7.49 (t, J=7.2 Hz, 2H), 7.40 (t, 
J=7.2 Hz, 1H), 2.79 (t, J= 7.2 Hz, 2H), 1.70-1.78 
(m, 2H), 1.32-1.40 (m, 6H), 0.89 (t, J= 6.8 Hz, 
3H). 
13C NMR (125.7 MHz, CDCl3) δ:137.2, 129.6, 
128.2, 120.3, 118.8, 31.5, 29.3, 28.9, 25.6, 22.5, 
14.7.  
HRMS Calculated for C14H20N3 (MH+): 230.320; 
found: 230.174. 
4.5 
5 - Ethyl 1-phenyl-1, 2, 3-triazole-4-
carboxylate 
 
White solid;  
1H NMR (500 MHz, CDCl3) δ: 8.56 (s, 1H), 7.79 
(d, J= 8.0 Hz, 2H), 7.57-7.54 (m, 2H), 7.51-7.48 
(m, 1H), 4.46 (dd, J=7.0 Hz, 2H), 1.43 (t, J= 7.0 
Hz, 3H). 
13C NMR (125.7 MHz, CDCl3) δ:160.42, 140.60, 
136.15, 129.78, 129.34, 125.44, 120.62, 61.32, 
14.18.  
HRMS Calculated for C11H11N3O2Na (M+Na)+: 
240.223; found: 240.124. 
4.6 
4-[1-(4-iodophenyl)-1H-1, 2, 3-triazol-
4-yl]-N,N-dimethylaniline  
 
Pale yellow solid:  
1H NMR (500 MHz, (CD3)2CO) δ: 8.81 (s, 1H), 
7.98 (d, 2H, J ) 8.9 Hz), 7.86-7.73 (m, 4H), 6.84 
(d, 2H, J ) 8.9 Hz), 3.02 (s, 6H).  
13C NMR (500 MHz, (CD3)2CO) ä 150.4, 148.1, 
138.4, 136.4, 126.2, 121.6, 121.4, 117.7, 117.3, 
112.3, 93.8.  
HRMS Calculated for C16H15IN4 (M+), 391.221; 
found, 391.360. 
 
4.4.2. Preparation of 13N-labelled triazoles ([13N]4.1-[13N]4.6) in manual mode 
The synthesis of triazoles ([13N]4.1-[13N]4.6) were achieved by reaction of 13N-labelled 
aromatic azides with alkyne derivatives and aldehydes (See Figure 4.8).  
Nitrogen-13 can be produced in different chemical forms in biomedical cyclotrons and 
offers a large variety of synthetic possibilities for the preparation of PET radiotracers. In 
spite of its short half life (10 min.), nitrogen-13 demands for the development of fast, 
efficient and robust synthetic processes. This was especially significant in the work 
reported here, because the synthetic strategy was envisioned through a 4-steps process, in 
addition to one intermediate and one final purification steps.  
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In our previous work [26], we achieved the synthesis of 13N-labelled aryl azides by two 
approaches: (A) Reaction of aniline with sodium nitrite to yield the non-labelled 
diazonium salt and subsequent reaction with 13N-labelled azide ion (prepared by reaction 
of [13N]NO2- with hydrazine hydrate in acidic media); and (B) reaction of aniline with 
[13N]NO2- to yield the 13N-labelled diazonium salt and subsequent reaction with azide ion 
(prepared by reaction of sodium nitrite with hydrazine hydrate in acidic media). Our 
results showed that the radiolabel was almost quantitatively transferred to the azide 
under route (B). Therefore, this route was considered as the most appropriate to achieve 
optimal results and furthermore the experimental conditions of this part of the reaction 
were not optimised.  
 
Figure 4.8. Scheme of the 4-step synthetic process followed for the preparation of 13N-labelled 
substituted triazoles by reaction of 13N-labelled azides with alkynes (a) and aldehydes (b). 
It is worth mentioning that during the preparation of 13N-labelled azides, it is paramount 
to work under no-carried-added conditions, in order to achieve the final labelled triazoles 
in high specific activity (amount of radioactivity per unit mass) values. In other words, the 
preparation of the labelled diazonium salt had to be conducted without addition of non-
radioactive nitrite. This, conclusively, led to the situation in which the labelled specie in 
the (3+2) Huisgen cycloaddition reaction for the synthesis of 13N-labelled triazoles is the 
limiting reagent, as its concentration is much lower than any other reagent. Taking this 
into account, we first tackled the optimization of the experimental conditions for the 
[13N]4.1
[13N]4.2
[13N]4.3
[13N]4.4
[13N]4.5
[13N]4.6
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preparation of 13N-labelled triazoles by reaction of the labelled azides with alkynes (see 
Figure 4.8). During this process, the work was carried out manually in a lead-shielded hot 
cell (Manuela, Comecer) especially designed to conduct manual operations to have a better 
control of the individual steps. In all steps, quality control analysis performed after the 
reduction step showed that 70-80% of the radioactivity eluted from the cadmium column 
was due to [13N]NO2-; non-reduced [13N]NO3- and [13N]NH4+ accounted for around 18-28% 
and 2% of the total radioactivity, respectively. These results are in good agreement with 
previous data [27-31]. 
After the preparation of labelled the azides, substantial amount of chemical impurities 
plus [13N]NH4+, [13N]NO3- and unreacted [13N]NO2- were present in the reaction mixture. In 
addition, subsequent reaction for the formation of the labelled triazole should be 
conducted in non-aqueous media. Because of this, the implementation of an intermediate 
step to change the solvent was required and we first approached to liquid-liquid 
extraction with dichloromethane. Radio-HPLC analysis of both the aqueous and organic 
phases confirmed quantitative extraction of the labelled azide. No peak corresponding to 
this specie was found in the aqueous phase. Furthermore, no radiochemical impurities (i.e. 
[13N]NH4+, [13N]NO3-, [13N]NO2- or labelled diazonium salt) were observed in the organic 
phase, although the presence of the starting aniline could be detected. This chemical 
impurity was anticipated not to interfere in the following copper mediated (3+2) Huisgen 
cycloaddition step.  
In order to set up the (3+2) Huisgen cycloaddition under hot conditions, the reaction was 
initially carried out using 13N-labelled phenylazide and phenylacetylene, using CuSO4.5H2O 
as the catalyst, mimicking the reaction conditions used during preparation of the non-
radioactive analogues. With that aim, the preparation of [13N]4.1 was approached by 
reaction of 13N-labelled phenylazide (redissolved in acetonitrile after evaporation of 
dichloromethane) with phenylacetylene in the presence of the catalyst (2 mg) for 10 min 
at RT. Unfortunately, the formation of the desired 13N-labelled triazole could not be 
detected by radio-HPLC. Similar results were obtained when copper (II) oxide (CuO) and 
copper (I) iodide were used as the catalyst. In view of this results, we decided to use 
[(Icy)2Cu]PF6 as the catalyst. This compound has proven efficient in a wide variety of (3+2) 
Huisgen cycloaddition reactions [32]. In this case, the reaction at RT for a period of 10 
minutes offered radiochemical conversion values (RCC, calculated from radio-
chromatographic profiles, expressed as the ratio between the area under the peak 
corresponding to 13N labelled triazole and the sum of the areas for all the peaks in the 
chromatogram, in percentage) of 15±2% (Table 4.3, entry 1). Further, during the 
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cycloaddition step the reaction at RT for a period of 20 minutes offered radiochemical 
conversion values of 50±3% (Table 4.4, entry 1). 
Table 4.3. Radiochemical conversion values for the preparation of 13N-labelled triazoles by 
reaction of 13N-labelled azides with alkynes or aldehydes at different temperatures. 
Entry Triazole RT 50°Ca/60°Cb 
1 [13N]4.1a 15±2 49±8 
2 [13N]4.2a 13±3 42±4 
3 [13N]4.3a 38±14 92±8 
4 [13N]4.4a 10±4 70±8 
5 [13N]4.5a 72±3 94±6 
6 [13N]4.6a 17±6 38±2 
7 [13N]4.1b 23±5 96±2 
aReaction of azide with alkyne; breaction of azide with aldehyde; values are expressed as average±standard 
deviation, n=3; RT: room temperature; reaction time was 10 min in all cases.   
After these encouraging results, we decided to extend the methodology by varying alkyne 
derivatives to the preparation of other functionalized triazoles ([13N]4.2-[13N]4.6), and 
different reaction temperatures were assayed. As it can be seen in tables 4.3-4.4, our 
method enabled the preparation of all 13N-labelled polysubstituted triazoles. 
Radiochemical conversion (RCC) values raised with temperature to reach acceptable 
values (38-94%) when the reaction was carried out at 50°C for a period of 10 minutes 
(Table 4.3, entries 1-6; see Figures 4.9a and 4.9b for examples of chromatographic profiles 
corresponding to the synthesis of [13N]4.1 at 50°C). Additionally, Radiochemical 
conversion (RCC) values raised with temperature to reach excellent values (55-99%) 
when the reaction was carried out at 50°C for 20 minutes (Table 4.4, entries 1-6). 
Interestingly, high RCC values were obtained when aliphatic alkynes were used. This 
result is not in agreement with previous works reported in the literature, as the fact that 
aliphatic alkynes are well known for their lower reactivity when compared to aromatic 
ones [33, 34]. However, in these previous works, long reaction times (hours) were used. 
Additionally, because we conducted all the reactions under no-carrier-added conditions, 
the intermediate 13N-labelled azide is the limiting reagent and its concentration is 
extremely low when compared to that of the alkyne derivative. Despite further 
investigation would be required, we hypothesize that the low RCC values obtained with 
aromatic triazoles might be due to the kinetics of the reaction.  
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Table 4.4. Radiochemical conversion values for the preparation of 13N-labelled triazoles by 
reaction of 13N-labelled azides with alkynes or aldehydes at different temperatures. 
Entry Triazole RT 50°Ca/60°Cb 
1 [13N]4.1a 50±3 70±8 
2 [13N]4.2a 45±4 62±6 
3 [13N]4.3a 55±14 98±8 
4 [13N]4.4a 12±4 86±8 
5 [13N]4.5a 78±5 99±4 
6 [13N]4.6a 23±6 55±4 
7 [13N]4.1b 39±4 98±2 
aReaction of azide with alkyne; breaction of azide with aldehyde; values are expressed as average±standard 
deviation, n=3; RT: room temperature; reaction time was 20 min in all cases.   
In view of the promising results, we decided to expand the scope of our work by tackling 
the preparation of [13N]4.1 by reaction of the labelled phenylazide with 
phenylacetaldehyde. In our first attempts, the reaction was carried out between 13N-
labelled phenylazide and phenylacetaldehyde, while [(Icy)2Cu]PF6 was used as the catalyst, 
but the formation of [13N]4.1 could not be detected by radio-HPLC. The formation of 
polysubstituted triazoles by reaction of azides with aldehydes has been previously 
reported in the literature [35]. In this previous work, 1,8-diazabicycloundec-7-ene (DBU) 
as the catalyst offered excellent results when the reaction was carried out in presence of 
DMSO as a solvent. In our hands, this catalyst offered good radiochemical conversion 
(RCC) values (23±5% and 39±4% when the reaction was conducted at room temperature 
for 10 and 20 minutes, respectively; see Tables 4.3 and 4.4, entry 7). The reaction was 
almost quantitative at T=60°C (see Figures 4.9c and 4.9d for examples of chromatographic 
profiles).  After these encouraging results, attempts to perform the reaction between 13N-
labelled phenylazide with other commercially available aldehydes under similar 
conditions were carried out. In this context, the preparation of [13N]4.3 was approached 
by reaction of 13N-labelled phenylazide with 1-hexanal in the presence of the DBU as a 
catalyst for 10 min and 20 min at RT and at T=60°C. Unfortunately, the formation of the 
desired 13N-labelled triazole could not be detected in both cases by radio-HPLC. 
Additionally the preparation of [13N]4.4 was approached by reaction of 13N-labelled 
phenylazide with 1-octanal in the presence of the DBU as a catalyst for 10 min and 20 min 
at RT and at T=60°C.  Unfortunately, the formation of the desired 13N-labelled triazole 
could not be detected again in both cases by radio-HPLC. Despite further experiments 
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might be required in order to elucidate the reason of such lack of reactivity, we postulate 
that aliphatic aldehydes are less reactive than aromatic aldehydes under hot conditions. 
 
Figure 4.9. Chromatographic profiles using radioactive (a, c) and UV (b, d) detection after analysis 
of the reaction crude corresponding to the synthesis of [13N]4.1; (a, b) synthesis by (3+2) 
cycloaddition using labelled phenylazide with phenylacetylene; (c,d) synthesis by (3+2) 
cycloaddition using labelled phenylazide with phenylacetaldehyde.    
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4.4.3. Implementation of an intermediate purification step based on SPE 
Liquid-liquid extraction using dichloromethane as an intermediate purification step is a 
very well established method for reactions that are conducted under non-radioactive 
conditions. However, such experimental step is quite tedious and sub-optimal in 
radioactive conditions because automatisation is extremely challenging. Therefore, and 
moving further towards the development of a fully automated process, other alternatives 
were explored. In previous works, during the synthesis of 13N-labelled azo compounds 
[28], our group has used solid phase extraction cartridges as a suitable tool to switch from 
aqueous to organic solvent. Here, we anticipated that dilution of the reaction crude with 
water after formation of the labelled intermediate phenylazide and subsequent elution 
through a C-18 cartridge would result in quantitative trapping of the labelled intermediate 
phenylazide. However, first attempts conducted with [13N]phenylazide were unsuccessful, 
and no trapping could be observed. Because the reaction for the formation of the 13N-
labelled phenylazide is carried out under strong acidic conditions, we postulated that the 
lack of retention might be due to the formation of the protonated form (positively 
charged) of the azide, which has low affinity for the C-18 cartridge phase. As expected, 
replacement of water by sodium acetate solution and subsequent elution through the C-18 
cartridge resulted in quantitative trapping of the labelled phenylazide, as revealed by 
radio-HPLC analysis of the eluate. In the case of [13N]p-iodophenylazide, used in the 
preparation of compound [13N]4.6, dilution with water led to quantitative trapping, 
probably due to the presence of the iodine atom, which confers a stronger hydrophobic 
character to the molecule, regardless of the net charge. 
Flushing of the C-18 cartridge with helium gas for 1 min was sufficient to remove the 
majority of the water; subsequent elution of the trapped labelled species with acetonitrile 
(1mL) and reaction with the corresponding alkyne derivatives under catalytic conditions 
led to the formation of the desired labelled polysubstituted triazoles ([13N]4.1 and 
[13N]4.6) with RCC values equivalent to those shown in table 4.3. 
Automatisation of the synthetic process for [13N] 4.6 
Replacement of liquid-liquid extraction by the solid phase extraction process as an 
intermediate purification step enabled the automatisation of the whole process (including 
final purification by semi-preparative HPLC) using the TracerlabTM FXFE synthesis module, 
with appropriate adaptation. The experimental conditions for the preparation of triazole 
[13N]4.6 were further optimized at this step. This triazole was specifically selected for full 
automatisation process because its non radioactive analogue has shown promising 
properties to target β-Amyloid aggregates, and therefore it may find application in the 
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early diagnose or evaluation of response to treatment in Alzheimer’s disease [24]. The 
amount of catalyst, the reaction time and the reaction temperature, for the formation of 
the labelled triazole were varied (Table 4.5). As it can be seen in the table, the formation of 
[13N]4.6  was not observed when the reaction time was set to 2 min, irrespective of the 
amount of catalyst (entries 1-3 in Table 4.5). It is worth mentioning the fact that heating of 
the reaction vial where the reaction is carried out starts at t=0. Hence, 2 min might not be 
sufficient to reach the desired temperature in the reaction mixture. Higher amount of 
catalyst, longer reaction times and higher temperature led to higher RCC values, as 
expected. At optimal reaction temperature (110°C), the reaction time of 10 min and 
amount of catalyst (10 mg), proved to be less desirable than the 5 min period, because the 
rise in RCC (approximately 10%, from 85 to 96%, see entries 12 and 13 in Table 4.5) was 
negligible compared with the short half life of nitrogen-13 (10 min) during the extra 5 min 
gap (close to 50%). Hence, T=110°C, t=5 min and amount of catalyst=10 mg were 
established as optimal conditions for [13N]4.6 among the investigated scenarios.     
Table 4.5. Radiochemical conversion values for the preparation of [13N]4.6 by reaction of 13N-
labelled 1-azido-4-iodobenzene with 4-ethynyl-N,N-dimethylaniline under different experimental 
conditions, using the automated synthesis box TracerlabTM FXFE 
Entry T (°C) T (min) Catalyst (mg) RCC (%) 
1 50 2 2 0 
2 50 2 5 0 
3 50 2 10 0 
4 50 5 2 16±5 
5 50 5 5 20±4 
6 50 5 10 22±5 
7 50 10 2 36±4 
8 50 10 5 49±7 
9 50 10 10 75±8 
10 80 5 10 40±3 
11 80 10 10 83±6 
12 110 5 10 85±9 
13 110 10 10 96±3 
Values are expressed as average ± standard deviation, n=3; catalyst: [(Icy)2Cu]PF6; RCC: Radiochemical 
conversion.    
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These optimised experimental conditions were applied for the fully automated 
preparation of pure [13N]4.6.  
 
 
Figure 4.10. (a) Chromatographic profile (radioactive detector) corresponding to the purification 
of [13N]4.6. Two radioactive peaks, corresponding to [13N]4.6 and unreacted 13N-labelled 1-azido-4-
iodobenzene, were found; (b,c) Chromatographic profiles (UV-Vis and radioactive detectors, 
respectively) corresponding to the analysis of purified [13N]4.6. No chemical nor radiochemical 
impurities were detected. 
After purification by semi-preparative HPLC (see Figure 4.10a for example of 
chromatographic profile) isolated radiochemical yields of 11±2%, related to the starting 
amount of 13N produced in the cyclotron and decay corrected to the end of the irradiation 
process, were obtained in overall production times of 25 min (non-decay corrected 
radiochemical yield = 2±0.4%). Specific activities at the end of the synthesis were 4.6±0.2 
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GBq/µmol, and radiochemical purity was >99% (Figure 4.10b) in all cases, as determined 
by radio-HPLC. No further chemical impurities were detected by HPLC (Figure 4.10c). 
Despite non-decay corrected radiochemical yields are low, an irradiation of 4 µAh yields 
around 6.6 GBq of 13N in the cyclotron target. Therefore, around 130 MBq (3.6 mCi) of 
pure radiotracer could be obtained at the end of the preparation process. Typical injected 
doses in rats and mice are around 500 and 100 µCi, respectively. Hence, the here reported 
methodology should enable subsequent in vitro or in vivo studies in small animal species. 
4.5. SUMMARY AND CONCLUSIONS 
In conclusion, we present here an unprecedented and fully automated methodology for 
the preparation of chemically and radiochemically pure 13N-labelled polysubstituted 
triazoles by reaction of 13N-labelled azides with alkynes via (3+2) Huisgen cycloaddition. 
The methodology could be extended to the preparation of triazoles in the (3+2) 
cycloaddition step using aromatic aldehydes and DBU as the catalyst. After optimization of 
the experimental conditions, sufficient amount of radiotracer to approach subsequent in 
vitro and in vivo studies in small animal species could be obtained. Radiolabelling using 13N 
may find interesting applications, especially in those instances in which incorporation of 
other positron emitters into the target molecule is not feasible, or to tackle the 
incorporation of the label in different positions to enable accurate metabolic studies.  
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5. NEW HETEROGENEOUS CATALYSTS: APPLICATION TO THE 
SYNTHESIS OF 13N-LABELLED TETRAZOLES 
5.1. INTRODUCTION 
Tetrazoles are heterocyclic compounds with molecular formula CH2N4, having a five-
membered ring with four nitrogen atoms and one carbon atom, and are unknown in 
nature. Tetrazoles are quite strong acids and readily form salts with transition metal ions. 
They emit toxic oxides of nitrogen fumes when heated to decomposition. Tetrazole salts 
are quite often heat- and shock- sensitive and therefore tetrazoles can be used as 
explosives or detonators. Tetrazoles exist in two tautomeric forms (Figures 5.1a and 5.1b), 
of which the 1H form (Figure 5.1 a) is dominant. 
 
Figure 5.1. Chemical structure of 1H-tetrazole in the two different tautomeric forms. 
Tetrazoles were first discovered in 1885 by J. A. Bladin [1] and can be prepared using 
different routes (see Table 5.1 for most relevant routes). Among tetrazoles, 5-substituted-
1H-tetrazoles have been an interesting field of study over the past few years, as various 
substituted tetrazoles are used as surrogates for carboxylic acids in pharmaceutically 
active agents, having higher lipophilicities and improved metabolic resistance [2]. They 
also find application in a variety of fields including materials sciences, information 
recording systems, rocket propellants, ligands, and precursors of a variety of nitrogen 
containing heterocycles in coordination chemistry [3-5]. Recently, tetrazole moieties were 
used for binding aryl thiotetrazolylacetanilides with HIV-1 reverse transcriptase [6].   
Several strategies for the synthesis of 5-substituted tetrazoles have been reported. The 
most common approach is the addition of the azide anion to nitrile or cyanamide groups in 
the presence of an acid catalyst [7]. However, this procedure has several drawbacks 
including the use of expensive and toxic metal organic azides [8] and strong Lewis acids 
[9]. An innovative and safe method for the synthesis of tetrazoles based on the addition of 
sodium azide to nitriles using stoichiometric amount of Zn(II) salts in water or 
dimethylformamide (DMF) as the solvent was later described [10]. However, this 
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CH3OC2H4OH, 100 °C
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EtO OEt
OEt
approach requires the tedious and time-consuming removal of zinc salts from the acidic 
products. 
Table 5.1. Production of tetrazoles 
Route Scheme 
First synthesis described: Reaction of 
anhydrous hydrazoic acid with 
hydrogen cyanide under pressure [11].  
(3 + 2) cycloaddition using inorganic 
azides (instead of hydrazoic acid) with 
benzonitrile [12]. 
 
Replacement of NaN3 by TMSN3. 
Formation of tetrazoles by reaction of 
TMSN3 with nitriles [13].  
Reaction of amines and triethyl 
orthoformate with sodium azide under 
catalytic conditions [14]. 
 
Reaction of alkenes, NBS, nitriles and 
TMSN3 under catalytic conditions to 
form various 1, 5-disubstituted 
tetrazoles [15]. 
 
Reaction of aryl diazonium salts with 
2,2,2-trifluorodiazoethane under mild 
conditions in the presence of a silver 
catalyst [16]. 
 
  
Pizzo and co-workers also reported an efficient method for synthesis of tetrazoles by the 
reaction of nitriles with TMSN3 (TMS=trimethylsilys) in the presence of tetra-n-
butylammonium fluoride (TBAF) as the catalyst [17]. Since then, various homo- and 
heterogeneous catalysts have been investigated including Brønsted acids, Lewis acids 
(BF3.OEt2), metal chlorides (AlCl3, CdCl2), metal oxides (Cu2O, ZnO, Sb2O3, γ-Fe2O3), clay 
and modified clay, Cu-incorporated ordered hexagonal mesoporous silicates (Cu-MCM-
41), FeCl3/SiO2, BaWO4, ZnS, and natural natrolite zeolite [5, 9, 12, 18-20]. Although most 
of these methods are efficient, they have common drawbacks. Homogeneous catalytic 
processes require expensive metal catalysts and hydrazoic acid, which is toxic and 
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explosive. Additionally, refluxing for a prolonged period of time and difficulty in 
separation and recovery of the catalyst result in tedious workup [21]. On the other hand, 
heterogeneous catalytic processes require a large excess of sodium azide, and long 
reaction times (24-96h) are usually needed to achieve acceptable reaction yields [22]. 
These reaction times are clearly too long for application to the preparation of 13N-labelled 
tetrazoles.   
Reaction times can be shortened by using microwave (MW) technology [5], and this could 
aid in the translation of the synthetic routes into the radiochemical field. Surprisingly, only 
a few works on the synthesis of 5-substitured tetrazoles using heterogenous catalysts 
under microwave irradiation conditions have been reported to date. One of the first works 
was based on the treatment of nitriles with sodium azide and ammonium chloride using 
DMF as the solvent in a closed vessel [23]. Under this experimental setting, isolated yields 
between 40 and 96% could be achieved (depending on the substrates) in short reaction 
times (10-25 min). The use of other heterogeneous catalysts such as Montmorillonite K-10 
clay and platinum nanoparticles decorated on activated carbon (Pt NPs@AC) has recently 
been reported [24, 25]. Microwave reactions have also been assayed using different 
homogenous catalysts, e.g. triethyl ammonium chloride in nitrobenzene [26], nitriles in 
ionic liquids[27], ZnCl2 [28, 29], and ZnBr2 [30]. However, as it has been mentioned above, 
the use of homogeneous catalysts poses several drawbacks in terms of purification, 
recovery of the catalyst and reusability.  
In this scenario, it is clear that the development of cheap, environment friendly, recyclable 
and efficient heterogeneous catalysts for the synthesis of tetrazoles under microwave 
assisted conditions is extremely challenging. In order to be useful in 13N-radiochemistry, 
the reaction for the formation of the tetrazoles should be completed in just a few minutes.   
5.2. AIM AND OBJECTIVES 
As it has been described in previous chapters, this PhD thesis initially focussed in the 
development of radiolabelling strategies for the preparation of 13N-labelled azides and 
triazoles. After achieving the initial goals, we decided to expand the range of applications 
of Nitrogen-13 by working on the development of synthetic strategies for the preparation 
of 13N-labelled tetrazoles with the radioactive atom placed in the heterocycle. Despite 
tetrazoles have been labelled with Nitrogen-15 [31], the synthesis of 13N-labelled 
tetrazoles is still unprecedented. After literature search, it was found that already 
described reactions under conventional heating required very long reaction times, which 
were not compatible with the short half-life of Nitrogen-13. Hence, the feasibility of other 
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alternatives such as microwave heating was explored. Indeed, we found that there are 
very few reports in the literature concerning the preparation of tetrazoles under 
microwave conditions using heterogeneous catalyst, and hence we decided to take 
advantage of the experience and knowledge of one of our collaborators, Dr. 
Chandrashekhar V. Rode (National Chemical Laboratory, Pune, India) to develop novel 
heterogeneous catalyst which may enable the conversion of azides into tetrazoles in a fast 
and efficient fashion.  
Based on the experience of our collaborator, the main goal was the development of 
nanostructured, copper based catalyst to assist in the production of tetrazoles via [3+2] 
cycloaddition involving the corresponding nitriles and sodium azide. The ultimate 
objective was to apply the newly developed catalysts to the production of one selected 
13N-labelled tetrazole as a model reaction. To achieve these general objectives, the 
following specific objectives were established:  
1. To prepare and characterize nanostructured copper-based catalysts. 
2. To develop a synthetic strategy for the preparation of a small library of tetrazoles  
by the reaction of sodium azide with nitriles using the copper-based 
nanostructured heterogeneous catalysts (developed in Objective 1) via (3+2) 
Huisgen cycloaddition. 
3. To apply the best heterogeneous catalyst to the preparation of one 13N-labelled 
tetrazole by the reaction of 13N-labelled azide with nitrile via (3+2) Huisgen 
cycloaddition. 
5.3. MATERIALS AND METHODS 
5.3.1. General Information 
Copper(II) nitrate trihydrate, aluminium nitrate nonahydrate, potassium carbonate, 
ammonium chromate and ammonium dichromate AR were purchased from Loba Chemie. 
Aluminium oxide was purchased from Chem-Labs. Benzonitrile (99%), 4-
chlorobenzonitrile, 4-(trifluoromethyl)benzonitrile (99%), p-tolunitrile (98%), 4-
methoxybenzonitrile (98%), (4-chlorophenyl)acetonitrile (96%), copper(I) oxide 
(>99.9%), zinc oxide (ACS reagent, >99.9%), Celite® S (filter aid, dried, untreated), silica, 
ammonia solution (28-30%), potassium carbonate (>99%), N-methylpyrrolidine (97%), 
N,N-dimethylformamide (>99%), methanol (anhydrous, >99.8%), dimethyl sulfoxide 
(anhydrous, >99.9%) and hydrochloric acid (37%, extrapure, Ph. Eur.) were purchased 
from Sigma-Aldrich and used without further purification. Hexane (synthesis grade), ethyl 
acetate (synthesis grade), dichloromethane (synthesis grade), acetonitrile (HPLC grade) 
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and diethyl ether (extra pure) were purchased from Scharlab. Ultrapure water (Type I 
water, ISO 3696) was obtained from a Milli-Q® purification system (Merck Millipore). 
5.3.2. Preparation of the catalysts 
The nano structured Cu–Al catalyst (50% content in Copper; named in the current PhD 
50%Cu-Al) was prepared by a simultaneous co-precipitation and digestion method with 
co-addition of an equimolar (0.05 M) mixture of an aqueous solution (250 mL) of 
Cu(NO3)2·3H2O (9.06 g), Al(NO3)3·9H2O (14.06 g) and 0.2 M aqueous K2CO3 (20.7 g in 250 
mL),  in a round bottom flask having 5–10 mL of water at room temperature. After 
complete addition, the precipitate was digested further for 4–5 h and then filtered and 
washed with deionized water to remove the traces of potassium. The precipitate was dried 
in an oven at 100 °C for 5–8 h. 
Cu-Al catalysts with chromium as a promoter having molar composition of 30%Cu, 39%Al 
and 31%Cr (named in the current PhD 30%Cu-Cr-Al) was prepared following a co-
precipitation method. The ammonium chromate solution was prepared by adding 15 mL 
of 30% aqueous ammonia solution to 100 mL aqueous ammonium dichromate solution 
(18.63 g). This was added under stirring in a thin stream to nitrate solution of metal 
precursors prepared by dissolving 18.12 g of Cu(NO3)2·3H2O and 36.38 g of Al(NO3)3·9H2O 
in 130 mL water. After complete addition, a reddish brown precipitate was obtained which 
was then filtered and dried at 100°C for 8 h.   
The last catalyst, named 20%Cu/SiO2 in the current PhD thesis, was prepared by a wet 
impregnation method. In brief, silica (3.2 g) was added to a solution of Cu(NO3)2·3H2O 
(3.04 g) in water (50 mL), and the slurry was stirred for 12 h. Excess water was then 
removed by rotavaporation and the residue was oven-dried at 100°C. All the three 
prepared catalysts were calcined at 400°C for 3 h prior to use.  
5.3.3. Characterization of the catalysts 
Powder X-ray diffraction patterns were recorded on a P Analytical PXRD system (Model X-
Pert PRO-1712), using Ni filtered Cu K radiation (λ= 0.154 nm) as an X-ray source at 30 
mA and 40 kV connected with an X-accelerator detector. 
Transmission electron microscopy (TEM) analyses were performed on a Jeol Model JEM 
1200 electron microscope operated at an accelerating voltage of 120 kV. A small amount 
of the sample was prepared by ultrasonically suspending the powder sample in ethanol. A 
drop of the suspension was deposited on a carbon coated copper grid and dried at room 
temperature before analysis. 
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Ammonia temperature programmed desorption (NH3-TPD) measurements were carried 
out on a Micromeritics-2720 (Chemisoft TPx) instrument. In order to evaluate the acidity 
of the catalysts, ammonia TPD measurements were carried out by (i) pre-treating the 
samples from room temperature to 473K under helium flow (25 mL min−1) for 2 h; (ii) 
adsorption of ammonia at 323K; and (iii) desorption of ammonia with a heating rate of 
283K min−1 starting from the adsorption temperature to 973K. The total amount of NH3 
desorbed was calculated by measuring the area of desorption peaks in both low and high 
temperature regions. 
5.3.4. Synthetic procedures: chemistry 
Six different tetrazoles (5.1-5.6) were prepared (see Figure 5.2).  
 
Figure 5.2. Tetrazoles prepared in this PhD thesis using the newly developed catalysts. Compound 
5.1 was also labelled with Nitrogen-13. 
The preparation of compounds 5.1-5.6 was carried out following a previously published 
method [32]. In brief, to a solution of anhydrous 30%Cu-Cr-Al (17mg) in NMP (1 mL) were 
added NaN3 (94.66 mg, 1.4563 mmol) and the corresponding nitrile (0.9708 mmol). The 
reaction mixture was stirred for 1 min at room temperature and was subsequently 
irradiated in a single-mode microwave instrument (Biotage Initiator 2.5) at 230°C for 3-20 
min. The reaction was monitored by TLC. The reaction crude was poured into 10 mL of 
H2O and the pH was adjusted to 1.0 with concentrated HCl (Caution: gas evolution). The 
mixture was cooled in an ice bath, the precipitate was collected by filtration and washed 
thoroughly with cold 1M HCl to yield the desired tetrazole. Characterization was 
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performed using 1H-NMR, 13C-NMR and Mass Spectrometry and data was compared to 
literature [13, 32]. 
5.3.5. Radiochemistry: Synthesis of [13N]5.1 
5.3.5.1. General  
All procedures were carried out under EU standards in terms of radioprotection and 
following internal procedures.  
5.3.5.2. Production of the primary labelling agent 
The whole synthetic procedure for the preparation of the labelled [13N]NO2- was carried 
out using same procedure followed in the chapters 3 and 4 (see above). 
5.3.5.3. Synthesis of 13N-labelled tetrazoles [13N]5.1 
The solution containing [13N]NO2- was added drop-wise to a second solution containing 
acetic acid (102 μL, 1.79 mmol) and hydrazine monohydrate solution (65 μL, 1.34 mmol) 
and the reaction for the formation of 13N-labelled azide was allowed to occur for 5 min. at 
room temperature (RT). The 13N-labelled azide was then added to a second solution 
containing benzonitrile (23 mg, 0.22 mmol), 30%Cu-Cr-Al Catalyst (4 mg of catalyst in 0.3 
mL of NMP) and the reaction was allowed to occur for 20 minutes at 200°C under 
conventional oil bath heating. After quenching the reaction by dilution with 0.1% TFA in 
water, chromatographic yield was determined by radio-HPLC, using an Agilent 1200 
Series HPLC system with a multiple wavelength UV detector (λ = 254 nm) and a 
radiometric detector (Gabi, Raytest). A RP-C18 column (Mediterranean Sea18, 4.6x250 
mm, 5 μm particle size) was used as the stationary phase and 0.1 % TFA in water (A)/ 0.1 
% TFA in acetonitrile (B) was used as the mobile phase, with the following gradient: t=0 
min, 90%A/10%B; t=10 min, 20%A/80%B; t=12 min, 20%A/80%B; t=15 min, 
90%A/10%B. The retention time for the labelled tetrazole was 7.4 min. 
5.4. RESULTS AND DISCUSSION 
5.4.1. Synthesis of tetrazoles (5.1-5.6) using  Copper based heterogeneous catalysts 
In this work, we explored the microwave assisted synthesis of 5-substituted 1H-tetrazole 
derivatives using copper-based nanostructures catalysts via [3+2] cycloaddition involving 
the corresponding nitriles and sodium azide in N-Methyl-2-pyrrolidone  (NMP) as the 
solvent (Figure 5.3). 
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Figure 5.3. Synthesis of  5-substituted 1H-tetrazoles by reaction of sodium azide with nitriles.   
5.4.2. Preparation and characterization of the catalysts 
Three different Copper based catalysts (named 20%Cu/SiO2, 50%Cu-Al, and 30%Cu-Cr-Al) 
were prepared and evaluated for the synthesis of 5-substitured 1H-tetrazoles by reacting 
the corresponding benzonitriles with sodium azide using NMP as the solvent. Before 
approaching the chemical reactions, the catalysts were thoroughly characterized by X-Ray 
diffraction (XRD), transmission electron microscopy (TEM) and NH3-temperature-
programmed desorption (NH3-TPD) in order to investigate the copper oxidation state, 
particle size and the acidity of the catalysts, respectively.     
In Figure 5.4, the XRD patterns of the catalysts after calcinations are shown. As it can be 
seen, 20%Cu/SiO2 catalyst showed narrow and high intensity peaks at 2θ values of 35.5 
(ī11), 38.7 (111) and small peaks centred at the 32.5° (110), 48.6° (¯202) 53.3° (020), 58.1° 
(202), 61.4° (113), 66.3° (¯311), 68.1° (220), 72.4° (311), and 75.1° (¯222) corresponding to 
CuO phase (PCPDF win no. 80-1917). The appearance of such sharp peaks was mainly due 
the impregnation method followed for the preparation of the catalyst. 30%Cu-Cr-Al 
catalyst showed CuO (2θ = 35.5°) phase together with broad, low intensity peaks at 2θ 
values of 37.3° (222), 18.2° (111), 30.4° (220), 43.3° (400), 57.2° (511), and 63.1° (440) 
corresponding to CuCr2O4 phase (PCPDF win no. 26-0509). However, 50%Cu-Al catalyst 
showed amorphous nature with a very small, broad peak at 2θ= 35.5° (ī11) corresponding 
to CuO phase. The lack of distinct peaks corresponding to CuO phase in 50%Cu-Al catalyst 
indicates the presence of small CuO particles. However, crystalline nature of the 
20%Cu/SiO2 catalyst points to the formation of larger Cu crystallites and/or particles 
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compared to that of Cu-Al and Cu-Cr-Al catalysts. In all cases, Cu was present in Cu(II) 
state, which is known to act as a Lewis acid and activates the nitrile group via coordination 
in tetrazole synthesis [33]. 
 
 
Figure 5.4. X-ray diffraction patterns of the Cu based catalysts.    
These results were supported by the HR-TEM images (Figure 5.5). Images acquired with 
50%Cu-Al and 30%Cu-Cr-Al catalysts showed dispersed, small and spherical particles 
with sizes in the ranges of 4-5 and 5-8 nm, respectively (Figures 5.5a, b, c, and d). The rod-
like shape evidenced in TEM images for 30%Cu-Cr-Al catalyst was associated with the 
boehmite phase of alumina (Figure 5.5a) [34]. However, slight aggregations with larger 
particles (17-28 nm) could be observed in the case of 20%Cu/SiO2 catalyst (Figures 5.5e 
and f). 
The acidity of the catalysts plays a pivotal role in the synthesis of tetrazoles. Because of 
this, the acidity and acid strength was investigated using NH3-TPD analysis (Figure 5.6). 
All the catalysts showed an NH3 desorption peak at approximately 90°C, which was due to 
desorption of physisorbed ammonia. The catalyst 20%Cu/SiO2 showed very less acidity 
with a small hump like peak at approximately 350°C, corresponding to moderate acid sites. 
The TPD profile of 50%Cu-Al catalyst showed peak maxima at 377.5°C and 502°C, and a 
high intensity peak at 652.8°C, confirming the presence of moderate and strong acid sites 
[35]. Similarly, 30%Cu-Cr-Al catalyst also showed the peaks corresponding to the 
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moderate and strong acid sites. However, NH3 desorption peak intensity at 652.8°C of 
50%Cu-Al catalyst was much higher compared to that of the 30%Cu-Cr-Al catalyst, 
indicating higher acidic strength of the 50%Cu-Al catalyst. Acidic strength values 
calculated based on total desorbed NH3 were 0.554 mmol g-1 for 50%Cu-Al, 0.446 mmol g-1 
for 30%Cu-Cr-Al, and 0.0684 mmol g-1 for 20%Cu/SiO2. Such difference in acidity was 
responsible for the difference in catalytic activity as discussed below.  
 
Figure 5.5. HR-TEM images of (a,b) Cu-Cr-Al, (c,d) Cu-Al and (e,f) Cu/SiO2 catalysts.    
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Figure 5.6. NH3-TPD profiles of Cu-based catalysts.   
5.4.3. Catalytic activity 
Copper based catalysts have been explored in the production of 5-substituted 1H-
tetrazoles by reaction of sodium azide and nitriles. As the solvent is known to play a 
pivotal role in tetrazole  synthesis [36], various solvents were initially evaluated in the 
presence and absence of catalyst and under different temperature conditions for 
compound 5.1 (see Table 5.2). Without the presence of the catalysts, no formation of the 
corresponding tetrazole could be observed, irrespective of the solvent (see Table 5.2, 
entries 1-4). Under catalytic conditions, none of the catalysts led to the formation of the 
desired tetrazole when the reaction was conducted in water or DMF/MeOH(9:1) as the 
solvent (Table 5.2, entries 5, 6, 9, 10 and 13), except 30%Cu-Cr-Al which resulted in 60% 
isolated yield (Table 5.2, entry 16). Interestingly, the three Cu-based catalysts showed 
excellent results in polar, aprotic solvents such as DMSO and NMP, both at 200°C and 
230°C (Table 5.2, entries 7 and 8 for 20%Cu/SiO2; entries 11 and 12 for 50%Cu-Al; entries 
17-19 for 30%Cu-Cr-Al). The enhanced catalytic properties of the catalysts in these media 
might be due to the high dipole moment of DMSO and the high nucleophilicity of NMP [2]. 
However, the time required to achieve maximum tetrazole formation was different for the 
three catalysts. When NMP was used as the solvent, 91% yields could be achieved with 
30%Cu-Cr-Al catalyst in 7 min reaction (Table 5.2, entry 18), while at the same 
temperature 15 minutes of reaction were required to achieve yields of 78 and 81% when 
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20%Cu/SiO2 and 50%Cu-Al were used, respectively. The yield obtained for 30%Cu-Cr-Al 
catalyst is significantly higher than that achieved with cuprous oxide and ZnO under 
identical experimental conditions (74% and 30%, respectively; see Table 5.2, entries 20 
and 21).  
Table 5.2: Synthesis of 5-phenyl-1H-tetrazole (5.1) in the presence of different Cu and Zn catalyst 
under different experimental conditions.a   
Entry Catalyst Solvent Time (min) T (°C) Yieldb (%) 
1 None Water 30 100 - 
2 None DMF/MeOH(9:1) 30 180 - 
3 None DMSO 30 200 - 
4 None NMP 30 230 - 
5 Cu-SiO2 Water 30 100 - 
6 Cu-SiO2 DMF/MeOH(9:1) 30 180 - 
7 Cu-SiO2 DMSO 25 200 84 
8 Cu-SiO2 NMP 15 230 78 
9 Cu-Al Water 30 100 - 
10 Cu-Al DMF/MeOH(9:1) 30 180 - 
11 Cu-Al DMSO 15 200 77 
12 Cu-Al NMP 15 230 81 
13 Cu-Cr-Al Water 30 100 - 
14 Cu-Cr-Al MeOH 30 100 30 
15 Cu-Cr-Al DMF 30 140 48 
16 Cu-Cr-Al DMF/MeOH(9:1) 30 140 60 
17 Cu-Cr-Al DMSO 15 200 75 
18 Cu-Cr-Al NMP 7 230 91 
19 Cu-Cr-Al NMP 7 200 77 
20 Cu2O NMP 7 230 74 
21 ZnO NMP 7 230 30 
a Reaction conditions: 0.97 mmol nitrile, 1.46 mmol NaN3, 17 mg catalyst, and 1.0 mL NMP; microwave heating 
at 230 °C. b Isolated yield.   
The lowest activity of 20%Cu/SiO2 with respect to 30%Cu-Cr-Al can be explained by the 
larger particle size (17-28 nm), which ultimately results in lower surface area (see Figure 
5.5). Interestingly, 50%Cu-Al catalyst shows higher acidity than 30%Cu-Cr-Al, but lower 
yields were obtained with the first under equivalent experimental conditions. This result 
suggests that moderate acid sites and addition of Cr to the catalyst contribute to enhance 
the catalytic activity.  
The effect of the reaction temperature on the catalytic activity of 30%Cu-Cr-Al was also 
investigated. When the temperature was decreased to 200°C, lower yield was achieved 
(77%; Table 5.2, entry 19). Optimal results were obtained with NMP as the solvent. Hence, 
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NMP was the solvent of choice to explore the application of the catalyst to the preparation 
of other tetrazoles (5.2-5.6). 
In order to check the scope of the prepared 30%Cu-Cr-Al catalyst for the synthesis of 5-
substituted 1H tetrazoles, different substituted nitriles were explored to prepare 
compounds 5.1-5.6 (see table 5.3 for characterization of the isolated tetrazoles).  
Table 5.3: Characterization of compounds 5.1-5.6.   
 Name / Structure Characterization data 
5.1 
5-Phenyl-1H-tetrazole 
 
1HNMR (400 MHz, DMSO-d6) δ 7.55-
7.60 (m, 3H, aromatic), 8.01-8.05 (m, 
2H, aromatic);  
13C NMR (125 MHz, DMSO-d6, δ, ppm): 
154.5 (tetrazole ring), 131.0, 130.2, 
127.2, 124.4;  
LCMS: calculated for C7H6N4 (MH+): 
147.149; found: 147.054. 
5.2 
 
5-(4’-Chlorophenyl) -1H-tetrazole 
  
1HNMR (400 MHz, DMSO-d6) δ 8.02 (d, 
J = 8.4 Hz, 2H, aromatic), 7.65 (d, J = 8.4 
Hz, 2H, aromatic);  
13C NMR (125 MHz, DMSO-d6): d 
=155.6, 135.2, 129.5, 128.2, 124.4;  
LCMS calculated for C7H5ClN4 (MH+): 
181.594; found: 181.006. 
5.3 
 
5-(4’-(Trifluoromethyl)phenyl)-1H-
tetrazole  
 
1H NMR (400 MHz, DMSO-d6) δ 8.21(d, 
J = 8.1 Hz, 2H, aromatic), 7.92 (d, J = 8.1 
Hz, 2H, aromatic);  
13C NMR (125 MHz, DMSO-d6): d 
=155.2, 131.2, 128.3, 127.6, 126.2, 
123.7;  
LCMS calculated for C8H5 F3N4 (MH+): 
215.147; found: 215.021. 
5.4 
 
5-(4’-Tolyl) -1H-tetrazole 
 
1H NMR (400 MHz, DMSO-d6) δ 7.96(d, 
J = 8.0 Hz, 2H, aromatic), 7.48 (d, J = 8.0 
Hz, 2H, aromatic), 2.30 (s, 3H, CH3);  
13C NMR (125 MHz, DMSO-d6, δ, ppm): 
154.8, 139.4, 130.4, 126.6, 121.4, 21.1;  
LCMS calculated for C8H8N4 (MH+): 
161.175; found: 161.067. 
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 Name / Structure Characterization data 
5.5 
 
5-(4’-Methoxyphenyl)-1H-tetrazole 
 
1HNMR (400 MHz, DMSO-d6) δ 7.94 (d, 
J = 9.0 Hz, 2H, aromatic), 7.13 (d, J = 9.0 
Hz, 2H, aromatic), 3.82 (s, 3H, CH3).  
13C NMR (125 MHz, DMSO-d6, δ, ppm): 
161.6, 154.4, 128.4, 116.4, 114.6, 55.2;  
LCMS calculated for C8H8N4O(MH+): 
177.175; found: 177.053. 
5.6 
5-((4’-Chlorophenyl)methyl)-1H-tetrazole  
 
1H NMR (400 MHz, DMSO-d6) δ 7.36 (d, J = 
8.4 Hz, 2H, aromatic), 7.27 (d, J = 8.4 Hz, 
2H, aromatic), 4.36 (s, 2H, CH2);  
 
13C-NMR (125 MHz, DMSO-d6, δ, ppm): 
154.4, 134.5, 131.2, 130.2, 128.2, 27.4; 
 
 LCMS calculated for C8H7ClN4 (MH+): 
195.620; Found: 195.508. 
 
The results (Table 5.4) show that all nitriles explored in this work react efficiently with 
sodium azide, and excellent yields within 3-20 min could be obtained, depending on the 
reactivity of the substrate. Nitriles having electron-withdrawing groups at the p- position 
(compounds 5.2-5.4, Table 5.4, entries 2-4) gave excellent yields in very short reaction 
times when compared to nitriles containing electron-donating groups on the same 
position (Table 5.4, compound 5.5, entry 5), which required prolonged reaction time [25]. 
This was an expected result, as the presence of electron-withdrawing groups increases the 
polarity of the cyanide group inductively, favouring thus the reaction. 4-Chlorophenyl 
acetonitrile (precursor for 5.6), was the less reactive precursor and required a reaction 
time of 20 min to yield the corresponding tetrazole in moderate yield (Table 5.4, entry 6).  
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Table 5.4: Preparation of tetrazoles 5.1-5.6 mediated by the Cu-Cr-Al catalyst.a   
Entry Compound Time (min) Yieldb (%) TON TOF (h-1) 
1 5.1 7 91 17.26 148.02 592.08c 
2 5.2 4 93 17.30 
 
259.52 
 
3 5.3 3 82 15.96 319.20  
4 5.4 6 85 16.04 160.4  
5 5.5 15 88 16.91 67.64  
6 5.6 20 77 14.26 42.78  
a Reaction conditions: 0.97 mmol nitrile, 1.46 mmol NaN3, 17 mg Cu-Cr-Al, and 1.0 mL NMP; 
microwave heating at 230°C. bIsolated yield. cTOF after fourth recycle; TON: Turn-over number, 
calculated as the molar ratio between desired product and catalyst; TOF: turn-over frequency, 
calculated as TON/reaction time. 
X-ray diffraction analyses revealed that copper was present in all catalysts mainly in the 
(II) oxidation state. This oxidation state is required to activate the nitrile group via 
coordination (see Figure 5.7 for a proposed reaction mechanism) [33]. This accelerates the 
cyclization step (a in the Figure 5.7) by enhancing the elecrophilic character of the cyanide 
group, which reacts with sodium azide to form the intermediate compound b. (see Figure 
5.7) Further protonation of b during the acid treatment results in the formation of a more 
stable tetrazole in tautomeric form (see Figure 5.7). 
One of the major advantages of heterogeneous catalysts arises from their recyclability. In 
order to proof the recyclability of our catalyst, five consecutive reactions were carried out. 
Between runs, the 30%Cu-Cr-Al catalyst was separated by centrifugation (5000 rpm) and 
washed twice with ultra pure water (5 mL). The catalyst was further dried by rotary 
evaporation and reused. With the fresh catalyst, the preparation of 5.1 could be achieved 
in 91% isolated yield when the reaction was conducted at 230°C for 7 min under MW 
heating. Under identical experimental conditions, isolated yields of 90%, 90%, 88% and 
87% were obtained in the second, third, fourth and fifth uses, respectively (Figure 5.8). 
These results suggest that the catalytic activity remains unaltered over the synthetic 
cycles, while the slight decrease in yield might be due to minor loss of the catalyst during 
the recycling process.   
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Figure 5.7. Plausible mechanism for the formation of tetrazoles.  
Figure 5.8. Reusability of the 30%Cu
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The results obtained in non
suitability of the catalyst to prepare 
configuration of our dependencies does not permit the application of microwave heating 
within the radiation controlled facilities. Because of this, the catalyst was assayed under 
0
20
40
60
80
100
1
Is
o
la
te
d
 y
ie
ld
 (
%
)
5: Synthesis of 13N-labelled tetrazoles 
 
-Cr-Al catalyst  for the synthesis of 5.1.   
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-radioactive conditions encouraged us to investigate the 
13N-labelled tetrazoles. However, the current 
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conventional heating using the automated synthesis modules currently available in our 
labs.  
When the reaction for the formation of the azide was conducted for 5 min, the presence of 
the desired labelled tetrazole could be identified after 20 min reaction under conventional 
heating (see Figure 5.9) with chromatographic yield of 20±4%. The product could be 
isolated by using semi-preparative HPLC. Despite the overall radiochemical yield after 
isolation was low (approximately 1%, not decay corrected) our experiments show the first 
example of 13N-labelled tetrazole. Implementation of microwave heating in the radiation-
controlled facility, full automatisation of the process and utilisation of the newly 
developed outstanding catalysts should lead to the formation of sufficient amount of 
labelled compound to approach in vivo imaging studies in small animals. 
 
Figure 5.9. Chromatographic profiles for the synthesis of [13N]5.1 using radioactivity (a) and UV 
(b) detectors. Reaction time for the formation of the tetrazole: 20 min.  
5.5. SUMMARY AND CONCLUSIONS 
In conclusion, we have prepared copper-based heterogeneous catalysts for the synthesis 
of 5-substituted 1H-tetrazoles from nitriles and sodium azide via (3+2) Huisgen 
cycloaddition. This nano-sized heterogeneous catalyst showed excellent activity for the 
preparation of different tetrazoles in short reaction time in the range 3-20 min at 230°C. 
Catalyst-recycling studies confirmed that 30%Cu-Cr-Al can be reused up to five 
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consecutive runs without significant loss of catalytic activity. The high catalytic efficiency 
of the newly developed catalyst enabled the preparation of one selected 13N-labelled 
tetrazole even under conventional heating. Translation of the experimental conditions to 
microwave heating should result in improved radiochemical yields, and hence the 13N-
labelled compounds may find application in the field of in vivo imaging using Positron 
Emission Tomography.     
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6. CONCLUDING REMARKS 
1. 13N-labelled aryl azides can be efficiently prepared by reaction of the 13N-labelled aryl-
diazonium salt with in situ generated hydrazoic acid.  
2. The experimental data combined with computational calculations support a stepwise 
mechanism via acyclic zwitterionic intermediates. 
3. The preparation of chemically and radiochemically pure 13N-labelled polysubstituted 
triazoles can be achieved by reaction of 13N-labelled azides with alkynes via (3+2) 
Huisgen cycloaddition. The same methodology can be applied to the preparation of 
triazoles using aromatic aldehydes and DBU as the catalyst, although this reaction 
does not work under radioactive conditions for aliphatic aldehydes.  
4. Automatisation of the radiosynthetic process described above enables the preparation 
of 13N-labelled triazoles in sufficient amount of radioactivity to approach putative in 
vivo studies in small animals.  
5. Copper based, nanostructured heterogeneous catalyst can be efficiently used for the 
preparation of 5-substituted 1H-tetrazoles by (3+2) Huisgen cycloaddition using 
nitriles and sodium azide under microwave heating in short reaction times. Isolated 
yields are higher than those obtained using conventional catalysts.   
6. The high catalytic efficiency of the copper-based nanostructured heterogeneous 
catalysts enabled the preparation of one selected 13N-labelled tetrazole under 
conventional heating.  
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ABBREVIATIONS 
 
 
 
ATP Adenosine triphosphate 
CT Computerised tomography 
DEAD Diethyl azodicarboxylate 
DFT Density functional theory 
DMF Dimethylformamide 
DMSO Dimethylsulfoxide 
GC Gas chromatography 
GC-MS 
BOC 
MW 
GSH 
Gas chromatography mass spectrometry 
Tert-butyloxycarbonyl 
Microwave 
Glutathione 
GMP Good manufacturing practices 
HPLC High-performance liquid chromatography 
HRMS High-Resolution Mass Spectrometry 
LC-MS Liquid chromatography–mass spectrometry 
MRI Magnetic resonance imaging 
MRS Magnetic resonance spectroscopy 
MS Mass spectrometry 
NBS N-Bromosuccinimide 
NMP N-Methyl-2-pyrrolidone 
OI Optical imaging 
PET Positron emission tomography 
RT Room temperature 
SN2Ar Aromatic nucleophilic substitution bimolecular    
SPE Solid phase extraction 
SPECT Single photon emission computerised tomography 
TDP Temperature programmed desorption  
TEM Transmission electron microscopy 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
US Ultra sound 
UV Ultraviolet 
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1, 4-Diphenyl-1H-1,2,3-triazole (4.1) 
 
 
 
 
4-Phenyl-1-p-tolyl-1H-1, 2, 3-triazole (4.2) 
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3 - 1-Phenyl-4-butyl-1,2,3-triazole (4.3) 
 
 
 
1-Phenyl-4-hexyl-1,2,3-triazole (4.4) 
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5 - Ethyl 1-phenyl-1,2,3-triazole-4-carboxylate (4.5) 
 
 
4-[1-(4-iodophenyl)-1H-1,2,3-triazol-4-yl]-N,N-dimethylaniline (4.6) 
 
 
 
 118 
5-Phenyl-1H-tetrazole (5.1) 
 
 
5-(4’-Chlorophenyl) -1H-tetrazole (5.2) 
 
 
 
 
 119 
5-(4’-(Trifluoromethyl)phenyl)-1H-tetrazole (5.3) 
 
 
 
5-(4’-Tolyl) -1H-tetrazole (5.4) 
 
 
 
 
 120 
5-(4’-Methoxyphenyl)-1H-tetrazole (5.5) 
 
 
5-((4’-Chlorophenyl)methyl)-1H-tetrazole (5.6) 
 
 
 
